<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with OASIS Tables v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-archive-oasis-article1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jats-oasis2jats3.xsl?><?ConverterInfo.Version 1?><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Microbiol Spectr</journal-id><journal-id journal-id-type="iso-abbrev">Microbiol Spectr</journal-id><journal-id journal-id-type="publisher-id">spectrum</journal-id><journal-title-group><journal-title>Microbiology Spectrum</journal-title></journal-title-group><issn pub-type="epub">2165-0497</issn><publisher><publisher-name>American Society for Microbiology</publisher-name><publisher-loc>1752 N St., N.W., Washington, DC</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">10100954</article-id><article-id pub-id-type="pmid">36847561</article-id><article-id pub-id-type="publisher-id">03852-22</article-id><article-id pub-id-type="doi">10.1128/spectrum.03852-22</article-id><article-id pub-id-type="publisher-id">spectrum.03852-22</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="article-attributes"><compound-subject><compound-subject-part content-type="code">open-peer-review</compound-subject-part><compound-subject-part content-type="label">Open Peer Review</compound-subject-part></compound-subject></subj-group><subj-group subj-group-type="biological-terms"><compound-subject><compound-subject-part content-type="code">applied-and-industrial-microbiology</compound-subject-part><compound-subject-part content-type="label">Applied and Industrial Microbiology</compound-subject-part></compound-subject></subj-group></article-categories><title-group><article-title>Comparative and Functional Analyses Reveal Conserved and Variable Regulatory Systems That Control Lasalocid Biosynthesis in Different <italic toggle="yes">Streptomyces</italic> Species</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Liu</surname><given-names>Minghao</given-names></name><xref rid="aff1" ref-type="aff">
<sup>a</sup>
</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Wang</surname><given-names>Kairui</given-names></name><xref rid="aff1" ref-type="aff">
<sup>a</sup>
</xref><xref rid="aff2" ref-type="aff">
<sup>b</sup>
</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Wei</surname><given-names>Junhong</given-names></name><xref rid="aff1" ref-type="aff">
<sup>a</sup>
</xref><xref rid="aff2" ref-type="aff">
<sup>b</sup>
</xref><xref rid="aff3" ref-type="aff">
<sup>c</sup>
</xref></contrib><contrib contrib-type="author" equal-contrib="no"><name><surname>Liu</surname><given-names>Ning</given-names></name><xref rid="aff1" ref-type="aff">
<sup>a</sup>
</xref></contrib><contrib contrib-type="author" equal-contrib="no"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-4796-5630</contrib-id><name><surname>Niu</surname><given-names>Guoqing</given-names></name><xref rid="aff1" ref-type="aff">
<sup>a</sup>
</xref><xref rid="aff4" ref-type="aff">
<sup>d</sup>
</xref></contrib><contrib contrib-type="author" equal-contrib="no"><name><surname>Tan</surname><given-names>Huarong</given-names></name><xref rid="aff1" ref-type="aff">
<sup>a</sup>
</xref><xref rid="aff2" ref-type="aff">
<sup>b</sup>
</xref></contrib><contrib contrib-type="author" corresp="yes" equal-contrib="no"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-7559-7070</contrib-id><name><surname>Huang</surname><given-names>Ying</given-names></name><xref rid="aff1" ref-type="aff">
<sup>a</sup>
</xref><xref rid="aff2" ref-type="aff">
<sup>b</sup>
</xref><email>huangy@im.ac.cn</email></contrib><aff id="aff1">
<label>a</label>
<addr-line>State Key Laboratory of Microbial Resources, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China</addr-line>
</aff><aff id="aff2">
<label>b</label>
<addr-line>College of Life Sciences, University of Chinese Academy of Sciences, Beijing, China</addr-line>
</aff><aff id="aff3">
<label>c</label>
<addr-line>State Key Laboratory of Silkworm Genome Biology, Southwest University, Chongqing, China</addr-line>
</aff><aff id="aff4">
<label>d</label>
<addr-line>Biotechnology Research Center, Southwest University, Chongqing, China</addr-line>
</aff></contrib-group><contrib-group><contrib contrib-type="editor"><role>Editor</role><name><surname>Tang</surname><given-names>Xiaoyu</given-names></name><aff>Shenzhen Bay Laboratory</aff></contrib></contrib-group><author-notes><fn fn-type="equal"><p>Minghao Liu, Kairui Wang, and Junhong Wei contributed equally to this work. Author order was determined alphabetically by their surname.</p></fn><fn fn-type="COI-statement"><p>The authors declare no conflict of interest.</p></fn></author-notes><pub-date publication-format="electronic" date-type="pub"><day>27</day><month>2</month><year>2023</year></pub-date><pub-date publication-format="electronic" date-type="collection"><season>Mar-Apr</season><year>2023</year></pub-date><pub-date pub-type="pmc-release"><day>27</day><month>2</month><year>2023</year></pub-date><!--PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>.--><volume>11</volume><issue>2</issue><elocation-id>e03852-22</elocation-id><history>
<date date-type="received"><day>20</day><month>9</month><year>2022</year></date>
<date date-type="accepted"><day>31</day><month>1</month><year>2023</year></date>
</history><permissions><copyright-statement>Copyright &#x000a9; 2023 Liu et al.</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Liu et al.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2023-02-27"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International license</ext-link>.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="spectrum.03852-22.pdf"/><self-uri content-type="reviewer_comments" xlink:href="reviewer-comments.pdf"/><abstract><title>ABSTRACT</title><p>Lasalocid, a representative polyether ionophore, has been successfully applied in veterinary medicine and animal husbandry and also displays promising potential for cancer therapy. Nevertheless, the regulatory system governing lasalocid biosynthesis remains obscure. Here, we identified two conserved (<italic toggle="yes">lodR2</italic> and <italic toggle="yes">lodR3</italic>) and one variable (<italic toggle="yes">lodR1</italic>, found only in <italic toggle="yes">Streptomyces</italic> sp. strain FXJ1.172) putative regulatory genes through a comparison of the lasalocid biosynthetic gene cluster (<italic toggle="yes">lod</italic>) from <italic toggle="yes">Streptomyces</italic> sp. FXJ1.172 with those (<italic toggle="yes">las</italic> and <italic toggle="yes">lsd</italic>) from <named-content content-type="genus-species">Streptomyces lasalocidi</named-content>. Gene disruption experiments demonstrated that both <italic toggle="yes">lodR1</italic> and <italic toggle="yes">lodR3</italic> positively regulate lasalocid biosynthesis in <italic toggle="yes">Streptomyces</italic> sp. FXJ1.172, while <italic toggle="yes">lodR2</italic> plays a negative regulatory role. To unravel the regulatory mechanism, transcriptional analysis and electrophoretic mobility shift assays (EMSAs) along with footprinting experiments were performed. The results revealed that LodR1 and LodR2 could bind to the intergenic regions of <italic toggle="yes">lodR1</italic>&#x02013;<italic toggle="yes">lodAB</italic> and <italic toggle="yes">lodR2</italic>&#x02013;<italic toggle="yes">lodED</italic>, respectively, thereby repressing the transcription of the <italic toggle="yes">lodAB</italic> and <italic toggle="yes">lodED</italic> operons, respectively. The repression of <italic toggle="yes">lodAB</italic>&#x02013;<italic toggle="yes">lodC</italic> by LodR1 likely boosts lasalocid biosynthesis. Furthermore, LodR2 and LodE constitute a repressor-activator system that senses changes in intracellular lasalocid concentrations and coordinates its biosynthesis. LodR3 could directly activate the transcription of key structural genes. Comparative and parallel functional analyses of the homologous genes in <named-content content-type="genus-species">S. lasalocidi</named-content> ATCC 31180<sup>T</sup> confirmed the conserved roles of <italic toggle="yes">lodR2</italic>, <italic toggle="yes">lodE</italic>, and <italic toggle="yes">lodR3</italic> in controlling lasalocid biosynthesis. Intriguingly, the variable gene locus <italic toggle="yes">lodR1</italic>&#x02013;<italic toggle="yes">lodC</italic> from <italic toggle="yes">Streptomyces</italic> sp. FXJ1.172 seems functionally conserved when introduced into <italic toggle="yes">S. lasalocidi</italic> ATCC 31180<sup>T</sup>. Overall, our findings demonstrate that lasalocid biosynthesis is tightly controlled by both conserved and variable regulators, providing valuable guidance for further improving lasalocid production.</p><p><bold>IMPORTANCE</bold> Compared to its elaborated biosynthetic pathway, the regulation of lasalocid biosynthesis remains obscure. Here, we characterize the roles of regulatory genes in lasalocid biosynthetic gene clusters of two distinct <italic toggle="yes">Streptomyces</italic> species and identify a conserved repressor-activator system, LodR2&#x02013;LodE, which could sense changes in the concentration of lasalocid and coordinate its biosynthesis with self-resistance. Furthermore, in parallel, we verify that the regulatory system identified in a new <italic toggle="yes">Streptomyces</italic> isolate is valid in the industrial lasalocid producer and thus applicable for the construction of high-yield strains. These findings deepen our understanding of regulatory mechanisms involved in the production of polyether ionophores and provide novel clues for the rational design of industrial strains for scaled-up production.</p></abstract><kwd-group><title>KEYWORDS</title><kwd>lasalocid</kwd><kwd>biosynthesis regulation</kwd><kwd>repressor-activator system</kwd><kwd>regulatory diversification</kwd><kwd><italic toggle="yes">Streptomyces</italic></kwd><kwd>biosynthetic gene cluster</kwd></kwd-group><funding-group specific-use="FundRef"><award-group award-type="grant" id="award1"><funding-source id="GS1">
<institution-wrap><institution>China Manned Space Engineering Program</institution></institution-wrap>
</funding-source><award-id>CMSE YYWT-0801-EXP-08</award-id><principal-award-recipient>
<name><surname>Huang</surname><given-names>Ying</given-names></name>
</principal-award-recipient></award-group><award-group award-type="grant" id="award2"><funding-source id="GS2">
<institution-wrap><institution>National Natural Science Foundation of China (NSFC)</institution><institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100001809</institution-id></institution-wrap>
</funding-source><award-id>31700008</award-id><principal-award-recipient>
<name><surname>Liu</surname><given-names>Minghao</given-names></name>
</principal-award-recipient></award-group><award-group award-type="grant" id="award3"><funding-source id="GS3">
<institution-wrap><institution>National Natural Science Foundation of China (NSFC)</institution><institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100001809</institution-id></institution-wrap>
</funding-source><award-id>81773615</award-id><principal-award-recipient>
<name><surname>Huang</surname><given-names>Ying</given-names></name>
</principal-award-recipient></award-group></funding-group><counts><count count="1" count-type="supplementary-material"/><fig-count count="8"/><table-count count="1"/><equation-count count="0"/><ref-count count="51"/><page-count count="19"/><word-count count="10179"/></counts><custom-meta-group><custom-meta><meta-name>cover-date</meta-name><meta-value>March/April 2023</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="s1"><title>INTRODUCTION</title><p>Actinobacteria, as the most abundant producers of secondary metabolites, produce a variety of complex polyketides with broad-spectrum biological activities (<xref rid="B1" ref-type="bibr">1</xref>). Among them, polyether ionophores are a unique class of type I polyketides featuring distinctive tetrahydrofuran and tetrahydropyran rings and are produced exclusively by actinobacteria. These polyketides have been successfully used in veterinary medicine and animal husbandry for more than half a century. Furthermore, they also display promising biological properties, including antiviral, antifungal, anticancer, and anti-inflammatory activities (<xref rid="B2" ref-type="bibr">2</xref>). The intriguing activities of ionophore agents can be attributed to their ability to chelate metal cations to form lipid-soluble complexes. These complexes facilitate cation transport across plasma membranes, resulting in membrane depolarization and subsequent cell damage or death (<xref rid="B2" ref-type="bibr">2</xref>, <xref rid="B3" ref-type="bibr">3</xref>). Lasalocid (<xref rid="B4" ref-type="bibr">4</xref>), one of the seven currently marketed carboxylic polyether ionophores, has been validated as a classical anticoccidial drug for poultry and a growth promoter in ruminants (<xref rid="B5" ref-type="bibr">5</xref>, <xref rid="B6" ref-type="bibr">6</xref>). Lasalocid selectively inhibits intracellular sporozoites while remaining relatively noninjurious to the host cell, and it has biased antimicrobial activity against Gram-positive bacteria, whereas most Gram-negative strains are still refractory (<xref rid="B7" ref-type="bibr">7</xref>). Recently, this ionophore has been verified as a novel inhibitor that protects cells from multiple deadly bacterial toxins via corrupting vesicular trafficking and Golgi stack homeostasis (<xref rid="B8" ref-type="bibr">8</xref>). Moreover, lasalocid and its synthetic analogs have shown high antiproliferative activity against cancer cell lines and, simultaneously, lower cytotoxicity toward nontumor cells than cisplatin, which hints at their potential to be developed as candidates for cancer treatment (<xref rid="B2" ref-type="bibr">2</xref>, <xref rid="B3" ref-type="bibr">3</xref>, <xref rid="B9" ref-type="bibr">9</xref>, <xref rid="B10" ref-type="bibr">10</xref>).</p><p>Given the broad-spectrum bioactivities and promising applications of polyether ionophores, increasing numbers of studies have been performed on the regulation of their biosynthesis. The biosynthetic gene clusters (BGCs) of nigericin (<italic toggle="yes">nig</italic>) and salinomycin (<italic toggle="yes">sln</italic>) both contain a single pathway-specific regulatory gene, and the overexpression of these genes greatly enhanced the production of the corresponding polyether ionophores (<xref rid="B11" ref-type="bibr">11</xref>, <xref rid="B12" ref-type="bibr">12</xref>). Unlike <italic toggle="yes">nig</italic> and <italic toggle="yes">sln</italic>, the BGCs of monensin (<italic toggle="yes">mon</italic>) and nanchangmycin (<italic toggle="yes">nan</italic>) each contain multiple regulatory genes that encode regulators belonging to diverse families, including LAL (large ATP-binding regulators of the LuxR family), SARP (<italic toggle="yes">Streptomyces</italic> antibiotic regulatory proteins), TetR, and AraC. These regulators form complex coregulatory cascades governing the biosynthesis of monensin and nanchangmycin (<xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B14" ref-type="bibr">14</xref>). In addition to the above-mentioned cluster-situated regulators (CSRs), the global transcriptional regulator DasR has also been proven to increase monensin production in <named-content content-type="genus-species">Streptomyces cinnamonensis</named-content> (<xref rid="B15" ref-type="bibr">15</xref>). However, although the biosynthetic pathway for lasalocid has been well elucidated (<xref rid="B16" ref-type="bibr">16</xref>), the regulatory mechanism in lasalocid production remains obscure, which hinders its titer improvement and further industrialization. Meanwhile, comparative genomics and phylogenetic analyses have revealed that even BGCs encoding the same molecule may vary in both gene content and organization (<xref rid="B17" ref-type="bibr">17</xref><xref rid="B18" ref-type="bibr">&#x02013;</xref><xref rid="B19" ref-type="bibr">19</xref>). These homologous BGCs normally keep conserved biosynthetic genes and relatively variable regulatory genes, the latter of which promote BGC diversification and can serve as evolutionary evidence (<xref rid="B20" ref-type="bibr">20</xref>, <xref rid="B21" ref-type="bibr">21</xref>). Several BGCs for polyether ionophores have been identified, while little is known about their regulatory diversification. Comparative dissection of their regulation systems may provide valuable insights into the evolution of these BGCs.</p><p>To date, lasalocid BGCs have been cloned from two closely related strains of <named-content content-type="genus-species">Streptomyces lasalocidi</named-content>, ATCC 31180<sup>T</sup> (<italic toggle="yes">las</italic>) and ATCC 35851 (<italic toggle="yes">lsd</italic>) (<xref rid="B22" ref-type="bibr">22</xref>, <xref rid="B23" ref-type="bibr">23</xref>), and were recently discovered from a potential novel species represented by red soil-derived <italic toggle="yes">Streptomyces</italic> sp. FXJ1.172 (<italic toggle="yes">lod</italic>) (<xref rid="B24" ref-type="bibr">24</xref><xref rid="B25" ref-type="bibr">&#x02013;</xref><xref rid="B26" ref-type="bibr">26</xref>). Here, to elucidate the pathway-specific regulatory mechanism in lasalocid biosynthesis, we conducted comparative and parallel functional analyses of the regulatory genes from different lasalocid BGCs. Compared to <italic toggle="yes">las</italic> and <italic toggle="yes">lsd</italic>, the <italic toggle="yes">lod</italic> cluster contains an exclusive regulatory gene, <italic toggle="yes">lodR1</italic>, in addition to the conserved <italic toggle="yes">lodR2</italic> and <italic toggle="yes">lodR3</italic> genes that are universal in the reported lasalocid BGCs. We reveal that both the variable and conserved regulatory genes are functional in different lasalocid BGCs, providing evidence for regulatory diversification. We also identified a conserved repressor-activator system composed of LodR2/Las3/Lsd6<italic toggle="yes">&#x02013;</italic>7 (unless otherwise specified, the dash indicates a range) and LodE/Las2/Lsd5, which is important for the control of lasalocid concentrations at appropriate levels in the producers.</p></sec><sec sec-type="results" id="s2"><title>RESULTS</title><sec id="s2-1"><title>Comparison of the lasalocid BGCs from <italic toggle="yes">Streptomyces</italic>.</title><p>In our previous study, we identified a 76,167-bp putative lasalocid gene cluster (<italic toggle="yes">lod</italic> [GenBank accession number <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/KT591188" ext-link-type="uri" assigning-authority="insdc">KT591188</ext-link>]) from the genome sequence of <italic toggle="yes">Streptomyces</italic> sp. FXJ1.172 (<xref rid="B26" ref-type="bibr">26</xref>). Bioinformatics analysis revealed that the cluster contains 22 open reading frames (ORFs), designated <italic toggle="yes">lodA&#x02013;lodT</italic>. In this study, to unravel the regulatory mechanism of lasalocid biosynthesis in different <italic toggle="yes">Streptomyces</italic> species, we first compared <italic toggle="yes">lod</italic> with the other two lasalocid gene clusters (<italic toggle="yes">las</italic> and <italic toggle="yes">lsd</italic> from <named-content content-type="genus-species">S. lasalocidi</named-content> strains). The results showed that all three BGCs share highly conserved biosynthetic genes and two regulatory genes (<italic toggle="yes">lodR2</italic> and <italic toggle="yes">lodR3</italic>) that encode MarR and LuxR family regulators, respectively (<xref rid="tab1" ref-type="table">Table&#x000a0;1</xref> and <xref rid="fig1" ref-type="fig">Fig.&#x000a0;1</xref>). Intriguingly, <italic toggle="yes">lod</italic> contains four exclusive ORFs: <italic toggle="yes">lodR1</italic>, encoding a TetR family regulator; <italic toggle="yes">lodA</italic>, encoding a protein with domains of unknown functions; <italic toggle="yes">lodB</italic>, encoding a monooxygenase; and <italic toggle="yes">lodC</italic>, encoding a 3-oxoacyl-ACP (acyl carrier protein) synthase that is much longer than its putative homologs encoded by <italic toggle="yes">orf09</italic> in <italic toggle="yes">las</italic> and <italic toggle="yes">lsd3</italic> in <italic toggle="yes">lsd</italic> (<xref rid="tab1" ref-type="table">Table&#x000a0;1</xref> and <xref rid="fig1" ref-type="fig">Fig.&#x000a0;1</xref>). This result illustrates the diversity of lasalocid BGCs in <italic toggle="yes">Streptomyces</italic>, notably the diversity of their regulatory elements.</p><fig position="float" id="fig1"><label>FIG&#x000a0;1</label><caption><p>Comparison of the genetic organizations of different lasalocid biosynthetic gene clusters. The figure was obtained using Easyfig, where grayscale bars represent regions of shared similarity according to BLASTN analysis.</p></caption><graphic xlink:href="spectrum.03852-22-f001" position="anchor"/></fig><table-wrap position="float" id="tab1"><label>TABLE&#x000a0;1</label><caption><p>Deduced functions of genes in the lasalocid biosynthetic gene cluster from <italic toggle="yes">Streptomyces</italic> sp. FXJ1.172</p></caption><alternatives><table frame="hsides" rules="groups"><colgroup span="1"><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/></colgroup><thead><tr><th rowspan="1" colspan="1">Gene</th><th rowspan="1" colspan="1">Product size (aa)</th><th rowspan="1" colspan="1">Homolog in <italic toggle="yes">las</italic> (% identity/% similarity)</th><th rowspan="1" colspan="1">Homolog in <italic toggle="yes">lsd</italic> (% identity/% similarity)</th><th rowspan="1" colspan="1">GenBank accession no. of protein homolog (% identity/% similarity); origin</th><th rowspan="1" colspan="1">Proposed function</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">
<italic toggle="yes">lodR1</italic>
</td><td rowspan="1" colspan="1">192</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"><ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/WP_076090794.1" ext-link-type="uri" assigning-authority="ncbiprotein">WP_076090794.1</ext-link> (97/97); <italic toggle="yes">Streptomyces</italic> sp. strain IMTB 2501</td><td rowspan="1" colspan="1">TetR family regulator</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">lodA</italic>
</td><td rowspan="1" colspan="1">148</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"><ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/WP_060890961.1" ext-link-type="uri" assigning-authority="ncbiprotein">WP_060890961.1</ext-link> (84/94); <named-content content-type="genus-species">Streptomyces europaeiscabiei</named-content></td><td rowspan="1" colspan="1">DUF1772 domain-containing protein</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">lodB</italic>
</td><td rowspan="1" colspan="1">116</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"><ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/WP_100602108.1" ext-link-type="uri" assigning-authority="ncbiprotein">WP_100602108.1</ext-link> (94/99); <italic toggle="yes">Streptomyces</italic> sp. strain CB02959</td><td rowspan="1" colspan="1">Antibiotic biosynthesis monooxygenase</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">lodC</italic>
<xref rid="ngtab1-1" ref-type="table-fn">
<sup>
<italic toggle="yes">a</italic>
</sup>
</xref>
</td><td rowspan="1" colspan="1">343</td><td rowspan="1" colspan="1"><italic toggle="yes">orf09</italic> (84/91)</td><td rowspan="1" colspan="1"><italic toggle="yes">lsd3</italic> (85/91)</td><td rowspan="1" colspan="1"><ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/WP_057602612.1" ext-link-type="uri" assigning-authority="ncbiprotein">WP_057602612.1</ext-link> (80/84); <italic toggle="yes">Streptomyces</italic> sp. strain Root1310</td><td rowspan="1" colspan="1">3-Oxoacyl-ACP synthase</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">lodD</italic>
</td><td rowspan="1" colspan="1">245</td><td rowspan="1" colspan="1"><italic toggle="yes">las1</italic> (83/90)</td><td rowspan="1" colspan="1"><italic toggle="yes">lsd4</italic> (83/90)</td><td rowspan="1" colspan="1"><ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/CAQ64680.1" ext-link-type="uri" assigning-authority="ncbiprotein">CAQ64680.1</ext-link> (83/90); <italic toggle="yes">Streptomyces lasalocidi</italic></td><td rowspan="1" colspan="1">Type II thioesterase</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">lodE</italic>
</td><td rowspan="1" colspan="1">522</td><td rowspan="1" colspan="1"><italic toggle="yes">las2</italic> (87/92)</td><td rowspan="1" colspan="1"><italic toggle="yes">lsd5</italic> (87/92)</td><td rowspan="1" colspan="1"><ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/BAG85020.1" ext-link-type="uri" assigning-authority="ncbiprotein">BAG85020.1</ext-link> (87/92); <italic toggle="yes">Streptomyces lasalocidi</italic></td><td rowspan="1" colspan="1">Putative resistance protein</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">lodR2</italic>
</td><td rowspan="1" colspan="1">161</td><td rowspan="1" colspan="1"><italic toggle="yes">las3</italic> (93/95)</td><td rowspan="1" colspan="1"><italic toggle="yes">lsd6&#x02013;7</italic> (93/95)</td><td rowspan="1" colspan="1"><ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/CAQ64682.1" ext-link-type="uri" assigning-authority="ncbiprotein">CAQ64682.1</ext-link> (93/95); <italic toggle="yes">Streptomyces lasalocidi</italic></td><td rowspan="1" colspan="1">MarR family regulator</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">lodR3</italic>
</td><td rowspan="1" colspan="1">884</td><td rowspan="1" colspan="1"><italic toggle="yes">las4</italic> (80/86)</td><td rowspan="1" colspan="1"><italic toggle="yes">lsd8</italic> (80/86)</td><td rowspan="1" colspan="1"><ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/CAQ64683.1" ext-link-type="uri" assigning-authority="ncbiprotein">CAQ64683.1</ext-link> (80/86); <italic toggle="yes">Streptomyces lasalocidi</italic></td><td rowspan="1" colspan="1">LuxR family regulator</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">lodF</italic>
</td><td rowspan="1" colspan="1">447</td><td rowspan="1" colspan="1"><italic toggle="yes">las5</italic> (91/94)</td><td rowspan="1" colspan="1"><italic toggle="yes">lsd9</italic> (92/95)</td><td rowspan="1" colspan="1"><ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/CAQ64684.1" ext-link-type="uri" assigning-authority="ncbiprotein">CAQ64684.1</ext-link> (91/94); <italic toggle="yes">Streptomyces lasalocidi</italic></td><td rowspan="1" colspan="1">Crotonyl-CoA reductase</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">lodG</italic>
</td><td rowspan="1" colspan="1">572</td><td rowspan="1" colspan="1"><italic toggle="yes">las6</italic> (85/90)</td><td rowspan="1" colspan="1"><italic toggle="yes">lsd10</italic> (85/90)</td><td rowspan="1" colspan="1"><ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/BAG85025.1" ext-link-type="uri" assigning-authority="ncbiprotein">BAG85025.1</ext-link> (85/90); <italic toggle="yes">Streptomyces lasalocidi</italic></td><td rowspan="1" colspan="1">3-Hydroxybutyryl-CoA dehydrogenase</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">lodH</italic>
</td><td rowspan="1" colspan="1">1,944</td><td rowspan="1" colspan="1"><italic toggle="yes">lasAI</italic> (80/85)</td><td rowspan="1" colspan="1"><italic toggle="yes">lsd11</italic> (80/85)</td><td rowspan="1" colspan="1"><ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/CAQ64686.1" ext-link-type="uri" assigning-authority="ncbiprotein">CAQ64686.1</ext-link> (80/85); <italic toggle="yes">Streptomyces lasalocidi</italic></td><td rowspan="1" colspan="1">Polyketide synthase</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">lodI</italic>
</td><td rowspan="1" colspan="1">710</td><td rowspan="1" colspan="1"><italic toggle="yes">lasAII</italic> (78/86)</td><td rowspan="1" colspan="1"><italic toggle="yes">lsd12</italic> (78/86)</td><td rowspan="1" colspan="1"><ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/CAQ64687.1" ext-link-type="uri" assigning-authority="ncbiprotein">CAQ64687.1</ext-link> (78/86); <italic toggle="yes">Streptomyces lasalocidi</italic></td><td rowspan="1" colspan="1">Polyketide synthase</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">lodJ</italic>
</td><td rowspan="1" colspan="1">1,115</td><td rowspan="1" colspan="1"><italic toggle="yes">lasAIII</italic> (84/89)</td><td rowspan="1" colspan="1"><italic toggle="yes">lsd13</italic> (84/89)</td><td rowspan="1" colspan="1"><ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/BAG85028.1" ext-link-type="uri" assigning-authority="ncbiprotein">BAG85028.1</ext-link> (84/89); <italic toggle="yes">Streptomyces lasalocidi</italic></td><td rowspan="1" colspan="1">Polyketide synthase</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">lodK</italic>
</td><td rowspan="1" colspan="1">1,650</td><td rowspan="1" colspan="1"><italic toggle="yes">lasAIV</italic> (82/87)</td><td rowspan="1" colspan="1"><italic toggle="yes">lsd14</italic> (82/87)</td><td rowspan="1" colspan="1"><ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/BAG85029.1" ext-link-type="uri" assigning-authority="ncbiprotein">BAG85029.1</ext-link> (82/87); <italic toggle="yes">Streptomyces lasalocidi</italic></td><td rowspan="1" colspan="1">Polyketide synthase</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">lodL</italic>
</td><td rowspan="1" colspan="1">3,071</td><td rowspan="1" colspan="1"><italic toggle="yes">lasAV</italic> (72/79)</td><td rowspan="1" colspan="1"><italic toggle="yes">lsd15</italic> (72/79)</td><td rowspan="1" colspan="1"><ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/CAQ64690.1" ext-link-type="uri" assigning-authority="ncbiprotein">CAQ64690.1</ext-link> (72/79); <italic toggle="yes">Streptomyces lasalocidi</italic></td><td rowspan="1" colspan="1">Polyketide synthase</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">lodM</italic>
</td><td rowspan="1" colspan="1">2,909</td><td rowspan="1" colspan="1"><italic toggle="yes">lasAI</italic> (76/82)</td><td rowspan="1" colspan="1"><italic toggle="yes">lsd11</italic> (76/82)</td><td rowspan="1" colspan="1"><ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/BAG85026.1" ext-link-type="uri" assigning-authority="ncbiprotein">BAG85026.1</ext-link> (76/82); <italic toggle="yes">Streptomyces lasalocidi</italic></td><td rowspan="1" colspan="1">Polyketide synthase</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">lodN</italic>
</td><td rowspan="1" colspan="1">5,437</td><td rowspan="1" colspan="1"><italic toggle="yes">lasAII</italic> (70/77)</td><td rowspan="1" colspan="1"><italic toggle="yes">lsd12</italic> (70/77)</td><td rowspan="1" colspan="1"><ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/CAQ64687.1" ext-link-type="uri" assigning-authority="ncbiprotein">CAQ64687.1</ext-link> (70/77); <italic toggle="yes">Streptomyces lasalocidi</italic></td><td rowspan="1" colspan="1">Polyketide synthase</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">lodO</italic>
</td><td rowspan="1" colspan="1">1,900</td><td rowspan="1" colspan="1"><italic toggle="yes">lasAVI</italic> (84/88)</td><td rowspan="1" colspan="1"><italic toggle="yes">lsd16</italic> (83/88)</td><td rowspan="1" colspan="1"><ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/CAQ64691.1" ext-link-type="uri" assigning-authority="ncbiprotein">CAQ64691.1</ext-link> (84/88); <italic toggle="yes">Streptomyces lasalocidi</italic></td><td rowspan="1" colspan="1">Polyketide synthase</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">lodP</italic>
</td><td rowspan="1" colspan="1">1,309</td><td rowspan="1" colspan="1"><italic toggle="yes">lasAVII</italic> (81/87)</td><td rowspan="1" colspan="1"><italic toggle="yes">lsd17</italic> (79/85)</td><td rowspan="1" colspan="1"><ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/CAQ64692.1" ext-link-type="uri" assigning-authority="ncbiprotein">CAQ64692.1</ext-link> (81/87); <italic toggle="yes">Streptomyces lasalocidi</italic></td><td rowspan="1" colspan="1">Polyketide synthase</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">lodQ</italic>
</td><td rowspan="1" colspan="1">122</td><td rowspan="1" colspan="1"><italic toggle="yes">las7</italic> (93/97)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"><ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/CAQ64693.1" ext-link-type="uri" assigning-authority="ncbiprotein">CAQ64693.1</ext-link> (93/97); <italic toggle="yes">Streptomyces lasalocidi</italic></td><td rowspan="1" colspan="1">Hypothetical protein</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">lodS</italic>
</td><td rowspan="1" colspan="1">472</td><td rowspan="1" colspan="1"><italic toggle="yes">lasC</italic> (89/93)</td><td rowspan="1" colspan="1"><italic toggle="yes">lsd18</italic> (89/93)</td><td rowspan="1" colspan="1"><ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/B5M9L6.1" ext-link-type="uri" assigning-authority="ncbiprotein">B5M9L6.1</ext-link> (89/93); <italic toggle="yes">Streptomyces lasalocidi</italic></td><td rowspan="1" colspan="1">Putative epoxidase</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">lodT</italic>
</td><td rowspan="1" colspan="1">275</td><td rowspan="1" colspan="1"><italic toggle="yes">lasB</italic> (85/91)</td><td rowspan="1" colspan="1"><italic toggle="yes">lsd19</italic> (85/90)</td><td rowspan="1" colspan="1"><ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/CAQ64695.1" ext-link-type="uri" assigning-authority="ncbiprotein">CAQ64695.1</ext-link> (85/91); <italic toggle="yes">Streptomyces lasalocidi</italic></td><td rowspan="1" colspan="1">Epoxide hydrolase</td></tr></tbody></table><graphic xlink:href="spectrum.03852-22_tab1" position="anchor"/></alternatives><table-wrap-foot><fn fn-type="other" id="ngtab1-1"><label>a</label><p>LodC (343 amino acids [aa]) is much longer than its putative homologs ORF09 (141 aa) and Lsd3 (144 aa).</p></fn></table-wrap-foot></table-wrap></sec><sec id="s2-2"><title>All three regulatory genes in <italic toggle="yes">lod</italic> function in controlling lasalocid biosynthesis in <italic toggle="yes">Streptomyces</italic> sp. FXJ1.172.</title><p>Three genes of the <italic toggle="yes">lod</italic> cluster are proposed to play a regulatory role in lasalocid biosynthesis in <italic toggle="yes">Streptomyces</italic> sp. FXJ1.172, including a variable gene (<italic toggle="yes">lodR1</italic>) and two conserved ones (<italic toggle="yes">lodR2</italic> and <italic toggle="yes">lodR3</italic>). To verify the functions of these genes, we constructed their mutants by disruptive in-frame deletions in the <italic toggle="yes">Streptomyces</italic> sp. FXJ1.172 wild type (FXJ1.172-WT) and designated them &#x00394;<italic toggle="yes">lodR1</italic>, &#x00394;<italic toggle="yes">lodR2</italic>, and &#x00394;<italic toggle="yes">lodR3</italic>, respectively. High-performance liquid chromatography (HPLC) analysis of the culture extracts from these mutants revealed a substantial loss of lasalocid production in the &#x00394;<italic toggle="yes">lodR1</italic> mutant and a complete loss in the &#x00394;<italic toggle="yes">lodR3</italic> mutant but a moderate increase in the &#x00394;<italic toggle="yes">lodR2</italic> mutant (<xref rid="fig2" ref-type="fig">Fig.&#x000a0;2</xref>). Complementation with <italic toggle="yes">lodR1</italic>, <italic toggle="yes">lodR2</italic>, and <italic toggle="yes">lodR3</italic> (inserted into pSET152 and driven by P<italic toggle="yes"><sub>kasO*</sub></italic>) in the corresponding mutants partially or completely restored lasalocid production (<xref rid="fig2" ref-type="fig">Fig.&#x000a0;2</xref>). These results indicate that <italic toggle="yes">lodR1</italic> and <italic toggle="yes">lodR3</italic> positively regulate lasalocid biosynthesis in <italic toggle="yes">Streptomyces</italic> sp. FXJ1.172, while <italic toggle="yes">lodR2</italic> plays a negative regulatory role.</p><fig position="float" id="fig2"><label>FIG&#x000a0;2</label><caption><p>HPLC analysis of lasalocid A production in the <italic toggle="yes">Streptomyces</italic> sp. FXJ1.172 wild type (FXJ1.172-WT) and its derivatives after fermentation for 240&#x02009;h. &#x00394;<italic toggle="yes">lodR1</italic>, &#x00394;<italic toggle="yes">lodR2</italic>, and &#x00394;<italic toggle="yes">lodR3</italic> represent <italic toggle="yes">lodR1</italic>, <italic toggle="yes">lodR2</italic>, and <italic toggle="yes">lodR3</italic> mutants, respectively, constructed by disruptive in-frame deletion; &#x00394;<italic toggle="yes">lodR1</italic>C, &#x00394;<italic toggle="yes">lodR2</italic>C, and &#x00394;<italic toggle="yes">lodR3</italic>C represent the corresponding complemented strains of the mutants. AU, arbitrary units.</p></caption><graphic xlink:href="spectrum.03852-22-f002" position="anchor"/></fig></sec><sec id="s2-3"><title>LodR1 positively regulates lasalocid biosynthesis by repressing the expression of adjacent <italic toggle="yes">lodA</italic>&#x02013;<italic toggle="yes">lodC</italic>, and this variable system of <italic toggle="yes">Streptomyces</italic> sp. FXJ1.172 seems to act similarly when introduced into <italic toggle="yes">S</italic>. <italic toggle="yes">lasalocidi</italic>.</title><p>The variable gene <italic toggle="yes">lodR1</italic> encodes a transcriptional regulator belonging to the TetR family, members of which are involved in various cellular activities, including but not limited to antibiotic production, quorum sensing, and the export of secondary metabolites (<xref rid="B27" ref-type="bibr">27</xref>, <xref rid="B28" ref-type="bibr">28</xref>). To unveil the regulatory mechanism of LodR1, we performed transcriptional analysis, electrophoretic mobility shift assays (EMSAs), and DNase I footprinting experiments. Cotranscriptional analysis of <italic toggle="yes">lod</italic> by reverse transcription-PCR (RT-PCR) revealed the existence of at least five transcriptional units (<italic toggle="yes">lodAB</italic>, <italic toggle="yes">lodED</italic>, <italic toggle="yes">lodR2</italic>&#x02013;<italic toggle="yes">F</italic>, <italic toggle="yes">lodH</italic>&#x02013;<italic toggle="yes">P</italic>, and <italic toggle="yes">lodST</italic>) and four individually transcribed genes (<italic toggle="yes">lodR1</italic>, <italic toggle="yes">lodC</italic>, <italic toggle="yes">lodG</italic>, and <italic toggle="yes">lodQ</italic>) (<xref rid="fig3" ref-type="fig">Fig.&#x000a0;3A</xref>). It is noteworthy that <italic toggle="yes">lodR2</italic> was cotranscribed with <italic toggle="yes">lodR3</italic> and <italic toggle="yes">lodF</italic> in one operon. Next, quantitative real-time RT-PCR (RT-qPCR) was conducted to investigate the effect of <italic toggle="yes">lodR1</italic> disruption on lasalocid biosynthesis at the transcriptional level. Total RNAs of FXJ1.172-WT and the &#x00394;<italic toggle="yes">lodR1</italic> mutant were isolated at days&#x02009;3 to 5. These time points were selected because lasalocid was initially detected in FXJ1.172-WT on the third day of fermentation, followed by a substantial increase in production over the next 2&#x02009;days (see Fig. S1 in the supplemental material). Compared to that in FXJ1.172-WT, the transcription of <italic toggle="yes">lodA</italic>&#x02013;<italic toggle="yes">lodC</italic> was greatly enhanced in the &#x00394;<italic toggle="yes">lodR1</italic> mutant (<xref rid="fig3" ref-type="fig">Fig.&#x000a0;3B</xref>), implying that LodR1 negatively regulates <italic toggle="yes">lodA</italic>&#x02013;<italic toggle="yes">lodC</italic>. In contrast, the transcript levels of the structural genes (<italic toggle="yes">lodF</italic>, <italic toggle="yes">lodG</italic>, <italic toggle="yes">lodH&#x02013;P</italic>, and <italic toggle="yes">lodST</italic>) were decreased in the &#x00394;<italic toggle="yes">lodR1</italic> mutant (<xref rid="fig3" ref-type="fig">Fig.&#x000a0;3B</xref>). To determine the target genes of LodR1, EMSAs were performed with all potential interoperonic promoters indicated in <xref rid="fig3" ref-type="fig">Fig.&#x000a0;3A</xref> and the intergenic region of <italic toggle="yes">lodR2&#x02013;lodR3</italic> (a possible intraoperonic promoter may exist in this region of over 500&#x02009;bp in length). Recombinant protein LodR1-His<sub>6</sub> was purified from <named-content content-type="genus-species">Escherichia coli</named-content> C41(DE3) containing expression plasmid pET23b::<italic toggle="yes">lodR1</italic>. The result showed that LodR1 could specifically bind to the intergenic region of <italic toggle="yes">lodR1</italic>&#x02013;<italic toggle="yes">lodA</italic> (P<italic toggle="yes"><sub>R1</sub></italic><sub>&#x02013;</sub><italic toggle="yes"><sub>A</sub></italic>) rather than to the other promoter regions in <italic toggle="yes">lod</italic> or the promoter region of <italic toggle="yes">hrdB</italic> (<xref rid="fig4" ref-type="fig">Fig.&#x000a0;4A</xref> and Fig. S2). LodR1 comprises an N-terminal DNA-binding domain and a C-terminal ligand-binding domain and shows high identity to SCO6121 from <named-content content-type="genus-species">Streptomyces coelicolor</named-content> and SVEN_3912 from <named-content content-type="genus-species">Streptomyces venezuelae</named-content> (both with 88% identity). To investigate the potential substrate of the ligand-binding domain in LodR1, EMSAs were performed with P<italic toggle="yes"><sub>R1</sub></italic><sub>&#x02013;</sub><italic toggle="yes"><sub>A</sub></italic> in the presence of different antibiotics (including lasalocid as the most probable ligand and other antibiotics with structural diversity, such as ampicillin, apramycin, and chloromycetin). Yet no perturbation of the DNA-binding activity of LodR1 was observed (data not shown), indicating that these antibiotics are not ligands of LodR1. To further elucidate the exact DNA-binding sites of LodR1, DNase I footprinting was carried out with probe P<italic toggle="yes"><sub>R1</sub></italic><sub>&#x02013;</sub><italic toggle="yes"><sub>A</sub></italic>. The results showed that LodR1 protected a region from nucleotide (nt) &#x02212;52 to nt +38 relative to the <italic toggle="yes">lodA</italic> transcription start point (TSP) (<xref rid="fig4" ref-type="fig">Fig.&#x000a0;4B</xref>). Analysis of this region identified a conserved recognition sequence (5&#x02032;-<named-content content-type="gene">CTAGCGTTGC</named-content>-3&#x02032;) forming a palindromic structure near the <italic toggle="yes">lodA</italic> TSP (<xref rid="fig4" ref-type="fig">Fig.&#x000a0;4C</xref>). Together, these data suggest that LodR1 directly represses the expression of <italic toggle="yes">lodAB</italic>. As <italic toggle="yes">lodC</italic> was not cotranscribed with <italic toggle="yes">lodAB</italic> and its intergenic region with <italic toggle="yes">lodB</italic> could not be recognized by LodR1, the increase in the <italic toggle="yes">lodC</italic> transcript level in the &#x00394;<italic toggle="yes">lodR1</italic> mutant is likely due to the indirect repression of <italic toggle="yes">lodC</italic> by LodR1.</p><fig position="float" id="fig3"><label>FIG&#x000a0;3</label><caption><p>Transcriptional analysis of the <italic toggle="yes">lod</italic> cluster. (A) Cotranscriptional analysis of the <italic toggle="yes">lod</italic> genes by RT-PCR. The regions used for PCR amplification are labeled 1 to 14; the operons (I to IX) and their transcriptional directions are marked by horizontal arrows. Total RNAs were isolated from FXJ1.172-WT after incubation for 96&#x02009;h and used for synthesizing cDNA. The genomic DNA (gDNA) was used as a positive control for the template. The 16S rRNA gene was used as a positive control for the genes. All potential interoperonic promoter regions are indicated by vertical arrows. (B) Transcriptional analysis of representative genes in <italic toggle="yes">lod</italic> from the FXJ1.172-WT, &#x00394;<italic toggle="yes">lodR1</italic>, &#x00394;<italic toggle="yes">lodR2</italic>, &#x00394;<italic toggle="yes">lodR3</italic>, and &#x00394;<italic toggle="yes">lodE</italic> strains by RT-qPCR. Total RNAs were isolated from the strains after incubation for 72, 96, and 120&#x02009;h. The relative transcript level of each gene was normalized against the level of the internal reference gene (16S rRNA) at the corresponding time points. Error bars show the standard deviations from three independent experiments. Data for the mutants were compared to those for FXJ1.172-WT, and statistical significance was determined by Student&#x02019;s <italic toggle="yes">t</italic> test. *, <italic toggle="yes">P</italic>&#x02009;&#x0003c;&#x02009;0.05; **, <italic toggle="yes">P</italic>&#x02009;&#x0003c;&#x02009;0.01; ***, <italic toggle="yes">P</italic>&#x02009;&#x0003c;&#x02009;0.001; ns, not significant.</p></caption><graphic xlink:href="spectrum.03852-22-f003" position="anchor"/></fig><fig position="float" id="fig4"><label>FIG&#x000a0;4</label><caption><p>Functional characterization of the regulator LodR1 in lasalocid biosynthesis. (A) EMSA of LodR1 binding to the intergenic region of <italic toggle="yes">lodR1</italic>&#x02013;<italic toggle="yes">lodA</italic>. All potential promoters indicated in <xref rid="fig3" ref-type="fig">Fig.&#x000a0;3A</xref> and the intergenic region of <italic toggle="yes">lodR2&#x02013;lodR3</italic> were used for EMSAs. P<italic toggle="yes"><sub>R1</sub></italic><sub>&#x02013;</sub><italic toggle="yes"><sub>A</sub></italic> and P<italic toggle="yes"><sub>hrdB</sub></italic> indicate the intergenic region of <italic toggle="yes">lodR1&#x02013;lodA</italic> and the promoter region of <italic toggle="yes">hrdB</italic>, respectively. (B) Determination of LodR1-binding sites on P<italic toggle="yes"><sub>R1&#x02013;A</sub></italic> by footprinting experiments. The concentrations of LodR1 used in lanes 1 to 5 were 0, 0.2, 0.4, 0.8, and 1.0&#x02009;&#x003bc;M, respectively. The bracket denotes the region protected by LodR1, and the numbers at the top indicate the distances relative to the transcription start point (TSP) of <italic toggle="yes">lodA</italic>. (C) Nucleotide sequences of the <italic toggle="yes">lodR1&#x02013;lodA</italic> intergenic region and LodR1-binding sites. The predicted TSP is indicated by a bent arrow. The LodR1-binding sites identified in the footprinting experiment are indicated between long lines, and the putative &#x02212;10 and &#x02212;35 regions are marked by boxes. The coding regions of <italic toggle="yes">lodA</italic> and <italic toggle="yes">lodR1</italic> are italicized. The inverted repeats are marked by arrows. (D) HPLC analysis of lasalocid A production in the <italic toggle="yes">Streptomyces lasalocidi</italic> ATCC 31180<sup>T</sup> wild type (31180-WT) and its derivatives 31180-KABC and 31180-R1ABC after fermentation for 240&#x02009;h. 31180-KABC contains plasmid pSET152 with locus <italic toggle="yes">lodA&#x02013;C</italic> driven by P<italic toggle="yes"><sub>kasO*</sub></italic>, and 31180-R1ABC contains plasmid pSET152 with locus <italic toggle="yes">lodR1&#x02013;C</italic>.</p></caption><graphic xlink:href="spectrum.03852-22-f004" position="anchor"/></fig><p>Although the <italic toggle="yes">lodR1</italic>&#x02013;<italic toggle="yes">lodC</italic> locus was found only in <italic toggle="yes">Streptomyces</italic> sp. FXJ1.172, we speculate that it might also function in heterologous lasalocid producers. To test this speculation, the <italic toggle="yes">lodA</italic>&#x02013;<italic toggle="yes">lodC</italic> and <italic toggle="yes">lodR1</italic>&#x02013;<italic toggle="yes">lodC</italic> loci were heterologously expressed in <italic toggle="yes">S. lasalocidi</italic> ATCC 31180<sup>T</sup> to generate strains 31180-KABC and 31180-R1ABC, respectively. As expected, the constitutive expression of <italic toggle="yes">lodA</italic>&#x02013;<italic toggle="yes">lodC</italic> resulted in a dramatic decrease in lasalocid production in 31180-KABC (<xref rid="fig4" ref-type="fig">Fig.&#x000a0;4D</xref>). In contrast, lasalocid production in 31180-R1ABC was comparable to that in the WT strain, which might be attributed to the inhibition of <italic toggle="yes">lodA</italic>&#x02013;<italic toggle="yes">lodC</italic> expression by LodR1. These findings suggest that the variable genes <italic toggle="yes">lodR1</italic> and <italic toggle="yes">lodA</italic>&#x02013;<italic toggle="yes">lodC</italic> seem to function conservatively in lasalocid biosynthesis in different <italic toggle="yes">Streptomyces</italic> species.</p></sec><sec id="s2-4"><title>LodR2 and LodE constitute a conserved repressor-activator system that senses changes in the concentration of lasalocid and coordinates its biosynthesis.</title><p>The regulatory protein encoded by <italic toggle="yes">lodR2</italic> contains DNA-binding domains with a characteristic winged helix-turn-helix fold that is conserved in the MarR family of transcriptional regulators (<xref rid="B29" ref-type="bibr">29</xref>). As a common feature of MarR members, these regulators can interact with specific ligands to modulate the DNA-binding affinity, thus regulating the transcription of their cognate genes (<xref rid="B30" ref-type="bibr">30</xref>). LodR2 exhibits extremely high identity (93%) to its homologs Las3 from <italic toggle="yes">S. lasalocidi</italic> ATCC 31180<sup>T</sup> and Lsd6<italic toggle="yes">&#x02013;</italic>7 (which should be an intact ORF but was likely interrupted and split into two truncated ORFs by misannotation) from <italic toggle="yes">S. lasalocidi</italic> ATCC 35851 (<xref rid="tab1" ref-type="table">Table&#x000a0;1</xref>), suggesting a conserved role of this MarR regulator in lasalocid biosynthesis. To functionally characterize the regulatory role of LodR2, experiments similar to those described above for LodR1 were carried out. RT-qPCR results showed that the transcript levels of <italic toggle="yes">lodR3</italic> and all of the structural genes were significantly increased in the &#x00394;<italic toggle="yes">lodR2</italic> mutant compared to those in FXJ1.172-WT (<xref rid="fig3" ref-type="fig">Fig.&#x000a0;3B</xref>). This finding indicates that LodR3 may activate the expression of structural genes. Meanwhile, the transcription of <italic toggle="yes">lodED</italic> was greatly enhanced in the &#x00394;<italic toggle="yes">lodR2</italic> mutant, indicating that LodR2 negatively regulates <italic toggle="yes">lodED</italic>. EMSAs of LodR2-His<sub>6</sub> with all potential interoperonic promoters and the intergenic region of <italic toggle="yes">lodR2&#x02013;lodR3</italic> also proved that LodR2 could specifically bind to the intergenic region of <italic toggle="yes">lodR2&#x02013;lodE</italic> (<xref rid="fig5" ref-type="fig">Fig.&#x000a0;5A</xref> and Fig. S2). Footprinting showed that LodR2 protected a region from nt &#x02212;65 to nt +88 relative to the <italic toggle="yes">lodE</italic> TSP (<xref rid="fig5" ref-type="fig">Fig.&#x000a0;5B</xref>). There is a conserved sequence, 5&#x02032;-<named-content content-type="gene">CATTCRT</named-content>-3&#x02032; (where R is A or G), in the <italic toggle="yes">lodR2</italic>&#x02013;<italic toggle="yes">lodE</italic> intergenic region, forming a palindromic structure near the TSP of <italic toggle="yes">lodR2</italic> (<xref rid="fig5" ref-type="fig">Fig.&#x000a0;5C</xref>). MarR family regulators, especially the cluster-situated ones, commonly have ligand-binding domains. To test whether the DNA-binding activity of LodR2 is modulated by lasalocid, EMSAs in the presence of different antibiotics were performed. The addition of lasalocid led to the dissociation of LodR2 from P<italic toggle="yes"><sub>R2&#x02013;E</sub></italic>, while the addition of the other antibiotics tested showed no effect on LodR2 (<xref rid="fig5" ref-type="fig">Fig.&#x000a0;5D</xref>), indicating that lasalocid interacts specifically with LodR2 and abolishes its DNA-binding activity.</p><fig position="float" id="fig5"><label>FIG&#x000a0;5</label><caption><p>Functional characterization of the regulator LodR2 in lasalocid biosynthesis. (A) EMSA of LodR2 binding to the intergenic region of <italic toggle="yes">lodE</italic>&#x02013;<italic toggle="yes">lodR2</italic>. All potential promoters indicated in <xref rid="fig3" ref-type="fig">Fig.&#x000a0;3A</xref> and the intergenic region of <italic toggle="yes">lodR2&#x02013;lodR3</italic> were used for EMSAs. P<italic toggle="yes"><sub>R2&#x02013;E</sub></italic> and P<italic toggle="yes"><sub>hrdB</sub></italic> indicate the intergenic region of <italic toggle="yes">lodR2</italic>&#x02013;<italic toggle="yes">lodE</italic> and the promoter region of <italic toggle="yes">hrdB</italic>, respectively. (B) Determination of LodR2-binding sites on P<italic toggle="yes"><sub>R2&#x02013;E</sub></italic> by footprinting experiments. The concentrations of LodR2 used in lanes 1 to 5 were 0, 0.2, 0.4, 0.8, and 1.0&#x02009;&#x003bc;M, respectively. The bracket denotes the region protected by LodR2, and the numbers at the top indicate the distances relative to the TSP of <italic toggle="yes">lodE</italic>. (C) Nucleotide sequences of the <italic toggle="yes">lodR2&#x02013;lodE</italic> intergenic region and LodR2-binding sites. The predicted TSP is indicated by a bent arrow. The LodR2-binding sequences identified in the footprinting experiment are indicated between long lines, and the putative &#x02212;10 and &#x02212;35 regions are marked by boxes. The coding regions of <italic toggle="yes">lodE</italic> and <italic toggle="yes">lodR2</italic> are italicized. The inverted repeats are marked by arrows. (D) Effects of different antibiotics on the DNA-binding activity of LodR2. Each lane contained probe P<italic toggle="yes"><sub>R2&#x02013;E</sub></italic>. Lanes 2 to 7 contained 100&#x02009;nM LodR2. (Left) Effects of lasalocid. Lanes 3 to 7 contained 0.4, 0.8, 1.6, 3.2, and 6.4&#x02009;&#x003bc;M lasalocid, respectively. (Right) Effects of ampicillin (amp), apramycin (apr), and chloromycetin (cm). Lanes 3 to 7 contained the antibiotics at a concentration of 3.2 or 6.4&#x02009;&#x003bc;M. (E) HPLC analysis of lasalocid A production in FXJ1.172-WT and its &#x00394;<italic toggle="yes">lodE</italic> and &#x00394;<italic toggle="yes">lodE</italic>C derivatives after fermentation for 240&#x02009;h. &#x00394;<italic toggle="yes">lodE</italic>, <italic toggle="yes">lodE</italic>-disruptive in-frame deletion mutant; &#x00394;<italic toggle="yes">lodE</italic>C, <italic toggle="yes">lodE</italic>-complemented &#x00394;<italic toggle="yes">lodE</italic> strain. (F) Intracellular (in) and extracellular (ex) distributions of lasalocid in FXJ1.172-WT and the &#x00394;<italic toggle="yes">lodE</italic> mutant. Error bars show the standard deviations from three independent experiments. Statistical significance was determined by Student&#x02019;s <italic toggle="yes">t</italic> test. *, <italic toggle="yes">P</italic>&#x02009;&#x0003c;&#x02009;0.05; **, <italic toggle="yes">P</italic>&#x02009;&#x0003c;&#x02009;0.01; ***, <italic toggle="yes">P</italic>&#x02009;&#x0003c;&#x02009;0.001; ns, not significant.</p></caption><graphic xlink:href="spectrum.03852-22-f005" position="anchor"/></fig><p>As the &#x00394;<italic toggle="yes">lodR2</italic> mutant exhibited enhanced lasalocid production and LodR2 directly repressed the transcription of <italic toggle="yes">lodED</italic> (<xref rid="fig2" ref-type="fig">Fig.&#x000a0;2</xref> and <xref rid="fig3" ref-type="fig">3</xref> and <xref rid="fig5" ref-type="fig">Fig.&#x000a0;5A</xref> to <xref rid="fig5" ref-type="fig">C</xref>), it was suggested that the proteins encoded by <italic toggle="yes">lodED</italic> could activate lasalocid biosynthesis. Based on the proposed functions of <italic toggle="yes">lodE</italic> and <italic toggle="yes">lodD</italic> (<xref rid="tab1" ref-type="table">Table&#x000a0;1</xref>), we speculate that <italic toggle="yes">lodE</italic> (encoding a putative resistance protein) is vital for lasalocid biosynthesis. To test our assumption, a <italic toggle="yes">lodE</italic> mutant (&#x00394;<italic toggle="yes">lodE</italic>) was constructed by disruptive in-frame deletion. Compared to FXJ1.172-WT, the &#x00394;<italic toggle="yes">lodE</italic> mutant produced much less lasalocid (<xref rid="fig5" ref-type="fig">Fig.&#x000a0;5E</xref>), which was consistent with the significantly decreased transcription of the structural genes <italic toggle="yes">lodF</italic>&#x02013;<italic toggle="yes">lodS</italic> in this mutant (<xref rid="fig3" ref-type="fig">Fig.&#x000a0;3B</xref>). Sequence alignment indicated that LodE belongs to the major facilitator superfamily of transporters with relatively high protein similarity to MonT (53% identity), a putative efflux protein responsible for self-resistance to monensin in <named-content content-type="genus-species">Streptomyces cinnamonensis</named-content> (<xref rid="B31" ref-type="bibr">31</xref>). To ascertain whether LodE acts as a transporter of lasalocid, we compared the intracellular and extracellular distributions of lasalocid in FXJ1.172-WT and the &#x00394;<italic toggle="yes">lodE</italic> mutant. As expected, the ratio of intracellular/extracellular lasalocid concentrations of the &#x00394;<italic toggle="yes">lodE</italic> mutant was significantly higher than that of FXJ1.172-WT (<xref rid="fig5" ref-type="fig">Fig.&#x000a0;5F</xref>), confirming that LodE is a transporter of lasalocid. Moreover, FXJ1.172-WT and the &#x00394;<italic toggle="yes">lodE</italic> mutant had comparable growth rates and biomasses (Fig. S3), excluding the possible effect of the growth perturbation of the mutant on lasalocid production.</p></sec><sec id="s2-5"><title>LodR3 positively regulates the expression of key structural genes in <italic toggle="yes">lod</italic>.</title><p>The third regulatory gene, <italic toggle="yes">lodR3</italic>, encodes a prototypical LuxR family transcriptional regulator containing an N-terminal ATPase domain and a putative C-terminal DNA-binding domain. The ATPase-associated LuxR regulators are usually involved in antibiotic biosynthesis in <italic toggle="yes">Streptomyces</italic> (<xref rid="B32" ref-type="bibr">32</xref>). LodR3 shows strong sequence identity (80%) to both Las4 from <italic toggle="yes">S. lasalocidi</italic> ATCC 31180<sup>T</sup> and Lsd8 from <italic toggle="yes">S. lasalocidi</italic> ATCC 35851 (<xref rid="tab1" ref-type="table">Table&#x000a0;1</xref>). RT-qPCR analysis supported the above-mentioned result that LodR3 could positively regulate lasalocid biosynthesis. Very few transcripts of the structural genes were detected in the &#x00394;<italic toggle="yes">lodR3</italic> mutant compared to FXJ1.172-WT (<xref rid="fig3" ref-type="fig">Fig.&#x000a0;3B</xref>), indicating that LodR3 is essential for initiating the transcription of the key structural genes. Unfortunately, all efforts to express soluble LodR3-His<sub>6</sub> were unsuccessful. Thus, <italic toggle="yes">gusA</italic> transcriptional fusion assays were performed to determine the potential target genes of LodR3 as previously described (<xref rid="B33" ref-type="bibr">33</xref>). According to the results of the cotranscriptional analysis mentioned above (<xref rid="fig3" ref-type="fig">Fig.&#x000a0;3A</xref>), the putative promoters of <italic toggle="yes">lodC</italic>, <italic toggle="yes">lodG</italic>, <italic toggle="yes">lodH</italic>, <italic toggle="yes">lodQ</italic>, <italic toggle="yes">lodS</italic>, and the intergenic region of <italic toggle="yes">lodR2&#x02013;lodR3</italic> were tested using <named-content content-type="genus-species">Streptomyces coelicolor</named-content> M1146 as a host (<xref rid="fig6" ref-type="fig">Fig.&#x000a0;6A</xref>). As a result, blue color was detected in <named-content content-type="genus-species">S. coelicolor</named-content> M1146 derivatives containing <italic toggle="yes">lodR3</italic> driven by P<italic toggle="yes"><sub>kasO*</sub></italic> and <italic toggle="yes">gusA</italic> driven by the above-mentioned promoters except for the <italic toggle="yes">lodC</italic> promoter (<xref rid="fig6" ref-type="fig">Fig.&#x000a0;6B</xref>). This result indicates that <italic toggle="yes">lodR3</italic> may have its own promoter in the intergenic region of <italic toggle="yes">lodR2&#x02013;lodR3</italic> in addition to cotranscription with <italic toggle="yes">lodR2</italic>. It also suggests that the promoters of <italic toggle="yes">lodR3</italic>, <italic toggle="yes">lodG</italic>, <italic toggle="yes">lodH</italic>, <italic toggle="yes">lodQ</italic>, and <italic toggle="yes">lodS</italic> are the targets of LodR3 and that LodR3 can therefore directly activate the transcription of <italic toggle="yes">lodR3&#x02013;F</italic>, <italic toggle="yes">lodG</italic>, <italic toggle="yes">lodH&#x02013;P</italic>, <italic toggle="yes">lodQ</italic>, and <italic toggle="yes">lodST</italic>.</p><fig position="float" id="fig6"><label>FIG&#x000a0;6</label><caption><p>Determination of the potential target genes of LodR3 by <italic toggle="yes">gusA</italic> transcriptional fusion assays. (A) Schematic diagram of <italic toggle="yes">gusA</italic> transcriptional fusions. Plasmid pSET152::P<italic toggle="yes"><sub>kasO*</sub></italic>-<italic toggle="yes">lodR3</italic> was used to overexpress <italic toggle="yes">lodR3</italic>, and the pIJ10500::P<italic toggle="yes"><sub>x</sub></italic>-<italic toggle="yes">gusA</italic> plasmid contains a reporter gene, <italic toggle="yes">gusA</italic>, driven by the promoter (P<italic toggle="yes"><sub>x</sub></italic>) of <italic toggle="yes">lodC</italic>, <italic toggle="yes">lodR3</italic>, <italic toggle="yes">lodG</italic>, <italic toggle="yes">lodH</italic>, <italic toggle="yes">lodQ</italic>, or <italic toggle="yes">lodS</italic>. Both pSET152::P<italic toggle="yes"><sub>kasO*</sub></italic>-<italic toggle="yes">lodR3</italic> and pIJ10500::P<italic toggle="yes"><sub>x</sub></italic>-<italic toggle="yes">gusA</italic> plasmids were introduced into <named-content content-type="genus-species">S. coelicolor</named-content> M1146 to determine the target genes of LodR3. (B) Chromogenic GUS assays of <named-content content-type="genus-species">S. coelicolor</named-content> M1146 derivatives. Potential promoters tested and their directions of transcription initiation are indicated by vertical and horizontal arrows, respectively. MP<italic toggle="yes"><sub>x</sub></italic>(&#x02212;) strains contain only pIJ10500::P<italic toggle="yes"><sub>x</sub></italic>-<italic toggle="yes">gusA</italic> plasmids, and MP<italic toggle="yes"><sub>x</sub></italic>(+) strains contain both pIJ10500::P<italic toggle="yes"><sub>x</sub></italic>-<italic toggle="yes">gusA</italic> and pSET152::P<italic toggle="yes"><sub>kasO*</sub></italic>-<italic toggle="yes">lodR3</italic> plasmids.</p></caption><graphic xlink:href="spectrum.03852-22-f006" position="anchor"/></fig></sec><sec id="s2-6"><title>Comparative and parallel functional analyses confirmed the conserved roles of <italic toggle="yes">lodE</italic>, <italic toggle="yes">lodR2</italic>, and <italic toggle="yes">lodR3</italic> homologs in controlling lasalocid biosynthesis in <italic toggle="yes">S. lasalocidi</italic>.</title><p><italic toggle="yes">S</italic>. <italic toggle="yes">lasalocidi</italic> strains are used as industrially valuable lasalocid producers, and thus, the regulatory mechanism of their lasalocid biosynthesis is worth dissecting for the construction of high-yield strains. As <italic toggle="yes">las</italic> and <italic toggle="yes">lsd</italic> are very similar clusters from the same species, we then selected <italic toggle="yes">las</italic> (which is from the publicly available <italic toggle="yes">S. lasalocidi</italic> type strain) to compare the functions of its regulatory genes with those in <italic toggle="yes">lod</italic>. Homologs of <italic toggle="yes">lodE</italic>, <italic toggle="yes">lodR2</italic>, and <italic toggle="yes">lodR3</italic> were identified in <italic toggle="yes">las</italic>, which have been designated <italic toggle="yes">las2</italic>, <italic toggle="yes">las3</italic>, and <italic toggle="yes">las4</italic>, respectively (<xref rid="B22" ref-type="bibr">22</xref>). To verify the role of these genes in lasalocid biosynthesis, the corresponding disruption mutants (&#x00394;<italic toggle="yes">las2</italic>, &#x00394;<italic toggle="yes">las3</italic>, and &#x00394;<italic toggle="yes">las4</italic>) were constructed from the <italic toggle="yes">S</italic>. <italic toggle="yes">lasalocidi</italic> ATCC 31180<sup>T</sup> wild type (31180-WT). Compared to that of 31180-WT, the lasalocid yield of the &#x00394;<italic toggle="yes">las2</italic> mutant was greatly reduced (from 33.8 to 4.7&#x02009;mg/L), and that of the &#x00394;<italic toggle="yes">las3</italic> mutant was increased (from 33.8 to 112.5&#x02009;mg/L), while lasalocid was no longer detected in the &#x00394;<italic toggle="yes">las4</italic> mutant (<xref rid="fig7" ref-type="fig">Fig.&#x000a0;7A</xref>). Complementation with the genes in the disruption mutants restored the yields (<xref rid="fig7" ref-type="fig">Fig.&#x000a0;7A</xref>). To verify the functional conservation of <italic toggle="yes">las4</italic> and its homolog <italic toggle="yes">lodR3</italic>, cross-complementation of the two genes was conducted. As a result, both the &#x00394;<italic toggle="yes">lodR3</italic> mutant cross-complemented with <italic toggle="yes">las4</italic> and the &#x00394;<italic toggle="yes">las4</italic> mutant cross-complemented with <italic toggle="yes">lodR3</italic> could restore lasalocid production to the level of the WT strains (<xref rid="fig7" ref-type="fig">Fig.&#x000a0;7B</xref>). Cotranscriptional analysis of <italic toggle="yes">las</italic> revealed the existence of at least four transcriptional units (<italic toggle="yes">las1</italic>&#x02013;<italic toggle="yes">2</italic>, <italic toggle="yes">las3</italic>&#x02013;<italic toggle="yes">5</italic>, <italic toggle="yes">lasAI</italic>&#x02013;<italic toggle="yes">lasAVII</italic>, and <italic toggle="yes">lasCB</italic>) and two individual transcriptional genes (<italic toggle="yes">las6</italic> and <italic toggle="yes">las7</italic>) (Fig. S4). Similar to their homologs in <italic toggle="yes">lod</italic>, <italic toggle="yes">las3</italic>&#x02013;<italic toggle="yes">5</italic> form a single operon. Likewise, RT-qPCR analysis of <italic toggle="yes">las</italic> genes in 31180-WT and the disruption mutants displayed transcriptional patterns similar to those observed for <italic toggle="yes">lod</italic> genes in <italic toggle="yes">Streptomyces</italic> sp. FXJ1.172 (<xref rid="fig7" ref-type="fig">Fig.&#x000a0;7C</xref>). Moreover, soluble Las3-His<sub>6</sub> protein was successfully expressed in <named-content content-type="genus-species">E. coli</named-content> BL21(DE3) using the expression plasmid pET28a::<italic toggle="yes">las3</italic>. Next, EMSAs and footprinting assays were performed to determine its target genes and binding sequences. As expected, Las3-His<sub>6</sub> formed complexes with the intergenic region of <italic toggle="yes">las2</italic>&#x02013;<italic toggle="yes">las3</italic> and protected a region from nt &#x02212;44 to nt +11 relative to the <italic toggle="yes">las2</italic> TSP (<xref rid="fig7" ref-type="fig">Fig.&#x000a0;7D</xref>). Analysis of the binding sites revealed an 8-bp palindromic sequence near the <italic toggle="yes">las2</italic> TSP (consensus, 5&#x02032;-<named-content content-type="gene">CATTMRTT</named-content>-3&#x02032; [where M is C or A and R is A or G]) (<xref rid="fig7" ref-type="fig">Fig.&#x000a0;7D</xref>), which is similar to the 5&#x02032;-<named-content content-type="gene">CATTCRT</named-content>-3&#x02032; (where R is A or G) sequence found in the <italic toggle="yes">lodR2</italic>&#x02013;<italic toggle="yes">lodE</italic> intergenic region from <italic toggle="yes">Streptomyces</italic> sp. FXJ1.172. All of these results are consistent with those for <italic toggle="yes">Streptomyces</italic> sp. FXJ1.172, indicating a conserved regulatory mechanism of lasalocid biosynthesis in the two species. Based on the above-described regulatory studies, high-yield lasalocid-producing strains were constructed by overexpressing <italic toggle="yes">las4</italic> in the &#x00394;<italic toggle="yes">las3</italic> mutant via a multicopy vector, pKC1139::P<italic toggle="yes"><sub>kasO</sub></italic><sub>*</sub><italic toggle="yes">las4</italic>, or a single-site integrative vector, pSET152::P<italic toggle="yes"><sub>kasO</sub></italic><sub>*</sub><italic toggle="yes">las4</italic>. The resultant mutants, &#x00394;<italic toggle="yes">las3</italic>-1139-<italic toggle="yes">las4</italic>OE and &#x00394;<italic toggle="yes">las3</italic>-152-<italic toggle="yes">las4</italic>OE, enhanced their lasalocid yields by 5.1 and 6.8 times, respectively, compared to 31180-WT (<xref rid="fig7" ref-type="fig">Fig.&#x000a0;7A</xref>). Overall, by the simultaneous disruption of the negative regulatory gene <italic toggle="yes">las3</italic> and the overexpression of the positive regulatory gene <italic toggle="yes">las4</italic>, we obtained high-yield strains with lasalocid production of up to 230&#x02009;mg/L.</p><fig position="float" id="fig7"><label>FIG&#x000a0;7</label><caption><p>Parallel functional verification of the <italic toggle="yes">lodE</italic>, <italic toggle="yes">lodR2</italic>, and <italic toggle="yes">lodR3</italic> homologs in <italic toggle="yes">las</italic> from <italic toggle="yes">S. lasalocidi</italic> ATCC 31180<sup>T</sup> and construction of high-yield lasalocid-producing strains. (A) Lasalocid A production in the <italic toggle="yes">S. lasalocidi</italic> ATCC 31180<sup>T</sup> wild type (31180-WT) and its derivatives. &#x00394;<italic toggle="yes">las2</italic>, &#x00394;<italic toggle="yes">las3</italic>, and &#x00394;<italic toggle="yes">las4</italic> denote <italic toggle="yes">las2</italic>, <italic toggle="yes">las3</italic>, and <italic toggle="yes">las4</italic> disruption mutants, respectively; &#x00394;<italic toggle="yes">las2</italic>C, &#x00394;<italic toggle="yes">las3</italic>C, and &#x00394;<italic toggle="yes">las4</italic>C denote the corresponding complemented strains of the disruption mutants; and &#x00394;<italic toggle="yes">las3</italic>-152-<italic toggle="yes">las4</italic>OE and &#x00394;<italic toggle="yes">las3</italic>-1139-<italic toggle="yes">las4</italic>OE denote <italic toggle="yes">las4</italic> overexpressed in the &#x00394;<italic toggle="yes">las3</italic> mutant via vector pSET152::P<italic toggle="yes"><sub>kasO*</sub>las4</italic> and vector pKC1139::P<italic toggle="yes"><sub>kasO*</sub>las4</italic>, respectively. (B) HPLC analysis of lasalocid A production in the &#x00394;<italic toggle="yes">lodR3</italic> mutant cross-complemented with <italic toggle="yes">las4</italic> (&#x00394;<italic toggle="yes">lodR3</italic>+<italic toggle="yes">las4</italic>C) and the &#x00394;<italic toggle="yes">las4</italic> mutant cross-complemented with <italic toggle="yes">lodR3</italic> (&#x00394;<italic toggle="yes">las4</italic>+<italic toggle="yes">lodR3</italic>C). (C) Transcriptional analysis of representative genes in <italic toggle="yes">las</italic> from the 31180-WT, &#x00394;<italic toggle="yes">las2</italic>, &#x00394;<italic toggle="yes">las3</italic>, and &#x00394;<italic toggle="yes">las4</italic> strains by RT-qPCR. Total RNAs were isolated from the strains after incubation for 120 and 144&#x02009;h. The relative transcript levels of each gene were normalized against the level of the internal reference gene (16S rRNA) at the corresponding time points. Error bars show the standard deviations from three independent experiments. Data for the mutants were compared to those for 31180-WT, and statistical significance was determined by Student&#x02019;s <italic toggle="yes">t</italic> test. *, <italic toggle="yes">P</italic>&#x02009;&#x0003c;&#x02009;0.05; **, <italic toggle="yes">P</italic>&#x02009;&#x0003c;&#x02009;0.01; ***, <italic toggle="yes">P</italic>&#x02009;&#x0003c;&#x02009;0.001; ns, not significant. (D) EMSA and footprinting experiment of Las3. P<italic toggle="yes"><sub>2&#x02013;3</sub></italic> represents the intergenic region of <italic toggle="yes">las2</italic> and <italic toggle="yes">las3</italic>, and the Las3-protected sequence in P<italic toggle="yes"><sub>2&#x02013;3</sub></italic> is indicated at the bottom of the graph, with the 8-bp palindromic sequence in red.</p></caption><graphic xlink:href="spectrum.03852-22-f007" position="anchor"/></fig></sec></sec><sec sec-type="discussion" id="s3"><title>DISCUSSION</title><p>Multiple regulatory genes coexist in lasalocid BGCs, but they may not form the complex coregulatory cascade process seen in the biosynthesis of monensin and nanchangmycin (<xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B14" ref-type="bibr">14</xref>). Our results reveal that lasalocid biosynthesis in different <italic toggle="yes">Streptomyces</italic> species is controlled by one variable and two conserved regulatory systems, providing an understanding of the regulatory diversification and mechanism. To our surprise, no intact homologs of <italic toggle="yes">lodR1</italic>&#x02013;<italic toggle="yes">lodC</italic> were identified in the NCBI nucleotide database. The presence of this variable locus in <italic toggle="yes">Streptomyces</italic> sp. FXJ1.172 could be partially ascribed to the divergent evolution of the regulation of lasalocid biosynthesis among streptomycetes. The distant phylogenetic relationship between <italic toggle="yes">Streptomyces</italic> sp. FXJ1.172 and <italic toggle="yes">S. lasalocidi</italic> (96.2% 16S rRNA gene sequence similarity and 81.7% genome-wide average nucleotide identity) (<xref rid="B24" ref-type="bibr">24</xref>) and their disparate soil origins, red soil in China (<xref rid="B25" ref-type="bibr">25</xref>) and park soil in the United States (<xref rid="B34" ref-type="bibr">34</xref>), respectively, both support the divergent-evolution hypothesis. Nevertheless, more lasalocid BGCs are needed to reconstruct an evolutionary roadmap of the biosynthesis regulation of this polyether. The <italic toggle="yes">lsd2</italic> gene, encoding a putative IclR family protein (<xref rid="B23" ref-type="bibr">23</xref>), might also have a regulatory role in lasalocid biosynthesis in <italic toggle="yes">S. lasalocidi</italic> ATCC 35851, albeit the whole sequence of <italic toggle="yes">lsd</italic> needs to be confirmed by genome sequencing. It was unexpected that the constitutive heterologous expression of <italic toggle="yes">lodA</italic>&#x02013;<italic toggle="yes">lodC</italic> from <italic toggle="yes">Streptomyces</italic> sp. FXJ1.172 also resulted in the diminished production of lasalocid in <italic toggle="yes">S. lasalocidi</italic> ATCC 31180<sup>T</sup>. This result suggests that these ORFs exclusive to <italic toggle="yes">lod</italic> can play a general role in the regulation of lasalocid biosynthesis in different <italic toggle="yes">Streptomyces</italic> species. Although we attributed the undisturbed lasalocid production in the mutant strain 31180-R1ABC to the inhibition of <italic toggle="yes">lodA&#x02013;lodC</italic> expression by LodR1, we cannot exclude another possibility, that all of these genes are not well expressed in the heterologous host, and more details are needed to further check whether the repression of the expression of <italic toggle="yes">lodA&#x02013;lodC</italic> by LodR1 is functionally conserved in <italic toggle="yes">S</italic>. <italic toggle="yes">lasalocidi</italic>. Additionally, based on their proposed roles (<xref rid="tab1" ref-type="table">Table&#x000a0;1</xref>), we presumed that <italic toggle="yes">lodA</italic>&#x02013;<italic toggle="yes">lodC</italic> might be involved in the biosynthesis of an unknown molecule, which shares substrates with lasalocid biosynthesis, thus leading to the reduced production of lasalocid. However, no additional metabolites were detected in <named-content content-type="genus-species">S. coelicolor</named-content> M1146 or <italic toggle="yes">S</italic>. <italic toggle="yes">lasalocidi</italic> ATCC 31180<sup>T</sup> derivatives containing heterologously expressed <italic toggle="yes">lodA</italic>&#x02013;<italic toggle="yes">lodC</italic> (data not shown). Notably, <italic toggle="yes">S. lasalocidi</italic> has only about 1/3 of LodC encoded within its lasalocid BGC, which keeps only a residue of the conserved domain found in LodC and thus looks like a truncated and useless protein (<xref rid="tab1" ref-type="table">Table&#x000a0;1</xref>). Our further work will focus on functional analyses of <italic toggle="yes">lodA</italic>, <italic toggle="yes">lodB</italic>, and <italic toggle="yes">lodC</italic> to determine how much of the reduced lasalocid production in different strains is due to <italic toggle="yes">lodAB</italic> versus <italic toggle="yes">lodC</italic> and to uncover their repression mechanism in lasalocid biosynthesis.</p><p>CSRs are often pathway-specific regulators that function as switches controlling the onset of antibiotic production (<xref rid="B32" ref-type="bibr">32</xref>). We used the consensus binding sequences found for LodR1 and LodR2 as queries for a local BLAST search against the genomes of <italic toggle="yes">Streptomyces</italic> sp. FXJ1.172 and <italic toggle="yes">S</italic>. <italic toggle="yes">lasalocidi</italic> ATCC 31180<sup>T</sup>, and we identified no other homologs. Thus, these regulators may not bind to the promoter regions of other genes, indicating that they tend to function as pathway-specific regulators instead of pleiotropic regulators. Nevertheless, antibiotics as well as their intermediates from the biosynthetic pathways can also modulate the activity of their cognate CSRs (<xref rid="B35" ref-type="bibr">35</xref>). This generates feedback regulation of antibiotic biosynthesis, which is important for self-protection against the overproduction of antibiotics (<xref rid="B32" ref-type="bibr">32</xref>, <xref rid="B36" ref-type="bibr">36</xref>, <xref rid="B37" ref-type="bibr">37</xref>). In this study, we demonstrate that lasalocid specifically binds to the MarR family transcription repressor LodR2 and causes its dissociation from the promoter region of <italic toggle="yes">lodR2&#x02013;lodE</italic> (<xref rid="fig5" ref-type="fig">Fig.&#x000a0;5B</xref>), thus activating the transcription of <italic toggle="yes">lodE</italic>. This finding coincides with the defining feature of MarR family regulators: they normally respond to specific ligands, resulting in attenuated DNA-binding activity and often the derepression of target gene transcription (<xref rid="B38" ref-type="bibr">38</xref>). Recently, a polyether antibiotic, calcimycin, has also been proven to inhibit the DNA-binding activity of its cognate CSR CalR3, which subsequently initiates the expression of the calcimycin transporter-encoding gene <italic toggle="yes">calT</italic> (<xref rid="B39" ref-type="bibr">39</xref>). Our results further verify that polyether antibiotics can act as modulating ligands of their cognate CSRs, and more polyether ionophores should be used to test the ligand-binding specificity of LodR2 in future studies. The transporter LodE is also crucial for lasalocid biosynthesis because disruption of <italic toggle="yes">lodE</italic> results in reduced lasalocid production and an increased ratio of intracellular/extracellular lasalocid concentrations. It is noteworthy that the residual production of lasalocid in the &#x00394;<italic toggle="yes">lodE</italic> mutant implies the existence of other efflux systems in the producer strain, as seen in the salinomycin producer <named-content content-type="genus-species">Streptomyces albus</named-content> BK3-25 (<xref rid="B40" ref-type="bibr">40</xref>). Intriguingly, the &#x00394;<italic toggle="yes">lodE</italic> mutant has an intracellular level of lasalocid equivalent to that of FXJ1.172-WT at day 4 but exhibits a greatly reduced transcriptional profile (<xref rid="fig3" ref-type="fig">Fig.&#x000a0;3B</xref> and <xref rid="fig5" ref-type="fig">Fig.&#x000a0;5F</xref>). A possible explanation for these differences observed is as follows. Lasalocid acts as an ionophore antibiotic, which facilitates cation transport across plasma membranes. Although the intracellular concentration of the <italic toggle="yes">lodE</italic> mutant is similar to that of FXJ1.172-WT at day 4, there are still significant differences between the intracellular and extracellular lasalocid concentrations in the &#x00394;<italic toggle="yes">lodE</italic> mutant. This may lead to the imbalance of ions across the membrane and subsequent cell damage. The cells may sense the changes in ion concentrations and thus downregulate the expression of <italic toggle="yes">lod</italic> to avoid self-damage. Additional transcriptome analysis will help to explain this confusing phenomenon that we observed.</p><p>The distribution of highly similar homologs of <italic toggle="yes">lodR2&#x02013;lodE</italic> in the other reported lasalocid BGCs highlights their indispensable role in the regulation of lasalocid biosynthesis. Furthermore, <italic toggle="yes">lodE</italic> homologs are also present in other polyether ionophore BGCs, i.e., <italic toggle="yes">idmC</italic>, <italic toggle="yes">monT</italic>, and <italic toggle="yes">ladT</italic> (with 67 to 69% nucleotide sequence identities to <italic toggle="yes">lodE</italic>) from the indanomycin, monensin, and laidlomycin (a monensin analog) gene clusters, respectively (<xref rid="B31" ref-type="bibr">31</xref>, <xref rid="B41" ref-type="bibr">41</xref>, <xref rid="B42" ref-type="bibr">42</xref>). Analogous to <italic toggle="yes">lodE</italic> coupled with <italic toggle="yes">lodR2</italic>, each of these homologous genes is flanked by a gene encoding a TetR/MarR family regulator (see Fig. S5 in the supplemental material). This observation indicates that similar regulatory systems may be widespread in different polyether producers. Hence, the disruption of these TetR/MarR family regulator-encoding genes or the overexpression of <italic toggle="yes">lodE</italic> homologs is potentially applicable for generating valuable polyether-overproducing mutants.</p><p>The large ATP-binding regulators of the LuxR family (LALs) often serve as CSRs in secondary metabolite biosynthesis in <italic toggle="yes">Streptomyces</italic> (<xref rid="B32" ref-type="bibr">32</xref>). Recently, a LAL member named SlnR was identified as a positive pathway-specific regulator in <named-content content-type="genus-species">Streptomyces albus</named-content> for the biosynthesis of salinomycin, another marketed carboxylic polyether ionophore (<xref rid="B11" ref-type="bibr">11</xref>). Akin to how SlnR modulates salinomycin biosynthesis by activating the transcription of most of the structural genes, LodR3 is essential for the transcription of genes responsible for the formation of the lasalocid skeleton (<xref rid="fig6" ref-type="fig">Fig.&#x000a0;6B</xref>). Based on the results of <italic toggle="yes">gusA</italic> assays and cotranscriptional analyses, <italic toggle="yes">lodR3</italic> may be dually controlled by itself and <italic toggle="yes">lodR2</italic>. The high sequence identity between <italic toggle="yes">lodR3</italic> and <italic toggle="yes">las4</italic> suggests the conserved role of this regulatory system in lasalocid biosynthesis, which is confirmed by the results of cross-complementation (<xref rid="fig7" ref-type="fig">Fig.&#x000a0;7B</xref>). Noticeably, both <italic toggle="yes">lodR3</italic> and <italic toggle="yes">las4</italic> contain rare TTA codons, suggesting that their expression may rely on the <italic toggle="yes">Streptomyces</italic> development-associated gene <italic toggle="yes">bldA</italic>, which encodes a tRNA for a rare leucine codon, UUA (<xref rid="B43" ref-type="bibr">43</xref>).</p><p>Taken together, we propose a plausible regulatory model for lasalocid biosynthesis (<xref rid="fig8" ref-type="fig">Fig.&#x000a0;8</xref>). In the early stage of <italic toggle="yes">Streptomyces</italic> sp. FXJ1.172 growth, LodR2 specifically binds to the bidirectional promoter region between <italic toggle="yes">lodR2</italic> and <italic toggle="yes">lodE</italic>, inhibiting the transcription of these two genes and part of <italic toggle="yes">lodR3</italic>. Meanwhile, <italic toggle="yes">lodR3</italic> has a separate promoter of its own, and LodR3 can initiate the transcription of most structural genes, leading to the production of lasalocid. When lasalocid accumulates and reaches a certain threshold in the cells, its allosteric interaction with LodR2 induces a conformational change, causing the dissociation of LodR2 from the <italic toggle="yes">lodE</italic> promoter region. Subsequently, the strong expression of <italic toggle="yes">lodE</italic>, which encodes an antibiotic efflux pump, results in a drop in the intracellular lasalocid concentration and then the continuous production of lasalocid. Thus, with the LodR2<italic toggle="yes">&#x02013;</italic>LodE system, the concentration of lasalocid in the producing strain is controlled at an appropriate level to avoid self-inhibition. Moreover, LodR1 positively regulates lasalocid biosynthesis by repressing the expression of adjacent <italic toggle="yes">lodA</italic>&#x02013;<italic toggle="yes">lodC</italic>, which seems to serve as an alternative regulatory system in addition to the conserved LodR2-LodE and LodR3 systems. In addition, a previously neglected gene, <italic toggle="yes">lodQ</italic> (homologous to <italic toggle="yes">las7</italic>), was unexpectedly identified as a putative target gene of LodR3 in <italic toggle="yes">gusA</italic> transcriptional fusion assays (<xref rid="fig6" ref-type="fig">Fig.&#x000a0;6B</xref>). <italic toggle="yes">lodQ</italic> (<italic toggle="yes">las7</italic>) encodes a hypothetical protein with no proposed function in lasalocid biosynthesis. However, the disruption of <italic toggle="yes">las7</italic> led to a remarkable decrease in lasalocid production in <italic toggle="yes">S. lasalocidi</italic> (Minghao Liu, Kairui Wang, and Ying Huang, unpublished data), implying an important role of <italic toggle="yes">lodQ</italic>/<italic toggle="yes">las7</italic> in lasalocid biosynthesis. Thus, the detailed function of <italic toggle="yes">lodQ</italic>/<italic toggle="yes">las7</italic> deserves further investigation. Based on our results, multiple genetic modifications can be performed to further improve lasalocid yields. These may include the overexpression of <italic toggle="yes">odR3</italic> (<italic toggle="yes">las4</italic> or <italic toggle="yes">lsd8</italic>), <italic toggle="yes">lodE</italic> (<italic toggle="yes">las2</italic> or <italic toggle="yes">lsd5</italic>), and <italic toggle="yes">dasR</italic>-like positive pleiotropic regulatory genes in a &#x00394;<italic toggle="yes">lodR2</italic> (&#x00394;<italic toggle="yes">las3</italic> or &#x00394;<italic toggle="yes">lsd6</italic>&#x02013;<italic toggle="yes">7</italic>) mutant.</p><fig position="float" id="fig8"><label>FIG&#x000a0;8</label><caption><p>Putative regulatory model for lasalocid production in <italic toggle="yes">Streptomyces</italic>. The <italic toggle="yes">lodR1&#x02013;lodC</italic> locus found exclusively in <italic toggle="yes">Streptomyces</italic> sp. FXJ1.172 is highlighted in a light-gray background. Black arrows, activation; black bars, repression; dashed line, the mechanism of repressing lasalocid production needs to be further clarified.</p></caption><graphic xlink:href="spectrum.03852-22-f008" position="anchor"/></fig></sec><sec sec-type="materials|methods" id="s4"><title>MATERIALS AND METHODS</title><sec id="s4-1"><title>Bacterial strains, plasmids, and growth conditions.</title><p>The strains and plasmids used in this study are listed in Tables S1 and S2, respectively, in the supplemental material. To harvest <italic toggle="yes">Streptomyces</italic> spores, <italic toggle="yes">Streptomyces</italic> sp. FXJ1.172 and its derivatives, <italic toggle="yes">S</italic>. <italic toggle="yes">lasalocidi</italic> ATCC 31180<sup>T</sup> and its derivatives, and <named-content content-type="genus-species">S. coelicolor</named-content> M1146 were grown at 28&#x000b0;C on International <italic toggle="yes">Streptomyces</italic> Project (ISP) medium 3 agar (<xref rid="B44" ref-type="bibr">44</xref>), glucose-yeast extract-malt extract (GYM) agar (<xref rid="B25" ref-type="bibr">25</xref>), and MS (2% mannitol, 2% soya flour) agar, respectively. <named-content content-type="genus-species">E. coli</named-content> strains for nucleic acid manipulation were cultured at 37&#x000b0;C in Luria-Bertani (LB) medium. When necessary, antibiotics were added at the following final concentrations: 100&#x02009;&#x003bc;g/mL ampicillin, 50&#x02009;&#x003bc;g/mL apramycin or kanamycin, and 25&#x02009;&#x003bc;g/mL chloramphenicol for <named-content content-type="genus-species">E. coli</named-content> and 25&#x02009;&#x003bc;g/mL apramycin, kanamycin, or nalidixic acid for <italic toggle="yes">Streptomyces</italic>.</p></sec><sec id="s4-2"><title>Construction of gene disruption and complementation mutants.</title><p>Nucleic acid manipulations were performed using standard procedures for <named-content content-type="genus-species">E. coli</named-content> (<xref rid="B45" ref-type="bibr">45</xref>) and <italic toggle="yes">Streptomyces</italic> (<xref rid="B46" ref-type="bibr">46</xref>) and according to the instructions of the manufacturers of the restriction enzymes and kits. The lasalocid BGC sequences and genome sequences of <italic toggle="yes">Streptomyces</italic> were obtained from the NCBI GenBank database. The <italic toggle="yes">Streptomyces</italic> mutant strains were constructed from wild-type strains by gene replacement via homologous recombination as previously described (<xref rid="B26" ref-type="bibr">26</xref>, <xref rid="B47" ref-type="bibr">47</xref>). For the genetic complementation of <italic toggle="yes">lodR1</italic>, a DNA fragment carrying the <italic toggle="yes">lodR1</italic> ORF was amplified by PCR using primers lodR1-orf-F and lodR1-orf-R (Table S3). The PCR product was gel purified and then ligated with EcoRV-digested pSET152 and a strong constitutive promoter, P<italic toggle="yes"><sub>kasO</sub></italic><sub>*</sub>, by Gibson assembly to give plasmid pSET152::P<italic toggle="yes"><sub>kasO*</sub>lodR1C</italic>. The recombinant plasmid was subsequently introduced into the <italic toggle="yes">lodR1</italic> mutant (&#x00394;<italic toggle="yes">lodR1</italic>) via conjugation to generate the &#x00394;<italic toggle="yes">lodR1</italic>C complemented strain. Other complemented strains and heterologous-expression strains were constructed similarly. The primers used in this study are listed in Table S3.</p></sec><sec id="s4-3"><title>Analysis of lasalocid production and bacterial biomass.</title><p>For lasalocid production, a suitable number of spores (~2.5&#x02009;&#x000d7;&#x02009;10<sup>6</sup>) of <italic toggle="yes">Streptomyces</italic> sp. FXJ1.172-WT, wild-type <italic toggle="yes">S. lasalocidi</italic> ATCC 31180<sup>T</sup>, or their mutants was inoculated into a 50-mL centrifuge tube containing 10&#x02009;mL of liquid tryptic soy broth (TSB) (pancreatic digest of 1.7% casein and papaic digest of 0.3% soybean, 0.25% dextrose, 0.5% NaCl, and 0.25% K<sub>2</sub>HPO<sub>4</sub> [pH 7.1 to 7.5]) and incubated on a rotary shaker at 220&#x02009;rpm at 28&#x000b0;C for 48&#x02009;h as a seed culture. Next, 1&#x02009;mL of the seed culture was transferred into 50&#x02009;mL of liquid SSC (2% soluble starch, 1% soybean powder, 0.5% calcium carbonate) medium. The cultures were incubated for different numbers of days at 28&#x000b0;C before sampling. For the analysis of lasalocid, 50&#x02009;mL of fermentation broth was centrifuged at 5,000&#x02009;rpm for 15&#x02009;min to separate the mycelia and the supernatant. The mycelia were extracted with 50&#x02009;mL of ethanol, and the supernatant was extracted with an equal volume of ethyl acetate. The extracts were combined and concentrated <italic toggle="yes">in vacuo</italic> to evaporate the solvent, and the residue was redissolved in 1.5&#x02009;mL of methanol (MeOH) for analysis. HPLC analysis was performed on a Shimadzu Prominence HPLC system using a Waters Xbridge octyl decyl silane column with a linear gradient of MeOH-H<sub>2</sub>O at a flow rate of 1.0&#x02009;mL/min. Mobile phases consisted of A: MeOH; and B: H<sub>2</sub>O. The following program was used to elute the column: 0 min, 20% A; 15 min, 100% A; 20.5 min, 100% A; 20.51 min, 20% A; 26.5 min 20% A. The effluent was monitored at 316&#x02009;nm. Tandem mass spectrometry identification of lasalocid was performed as previously described (<xref rid="B26" ref-type="bibr">26</xref>). The lasalocid A standard was used as a positive control for HPLC and mass spectrometry analyses to confirm the production of lasalocid (Fig. S6). The bacterial biomass was determined by measuring the cell dry weight. An aliquot of 2&#x02009;mL of the cell culture was harvested and centrifuged at 12,000&#x02009;rpm for 10&#x02009;min to separate the mycelia and the supernatant, and the mycelia were then dried at 50&#x000b0;C to a constant weight.</p></sec><sec id="s4-4"><title>RNA isolation and transcriptional analyses.</title><p>Total RNAs were isolated from <italic toggle="yes">Streptomyces</italic> sp. FXJ1.172 and its derivatives after incubation for 72, 96, and 120&#x02009;h in SSC medium as described previously (<xref rid="B48" ref-type="bibr">48</xref>). Likewise, total RNAs were isolated from <italic toggle="yes">S. lasalocidi</italic> ATCC 31180<sup>T</sup> and its derivatives after incubation for 120 and 144&#x02009;h in SSC medium. First-strand synthesis of cDNA was carried out with a Superscript III first-strand synthesis system (Invitrogen, CA, USA) using 1&#x02009;&#x003bc;g of total RNA in a total volume of 20&#x02009;&#x003bc;L according to the manufacturer&#x02019;s instructions. Cotranscriptional analysis was performed by RT-PCR according to previously reported procedures (<xref rid="B49" ref-type="bibr">49</xref>) to ascertain the transcriptional units of <italic toggle="yes">lod</italic> and <italic toggle="yes">las</italic>. Subsequent RT-qPCR of selected genes was carried out in a reaction mixture containing 10&#x02009;pmol of each primer and 1&#x02009;&#x003bc;L of cDNA in a total volume of 20&#x02009;&#x003bc;L. RT-qPCR was also conducted without reverse transcriptase to test DNA contamination in the RNA. The 16S rRNA gene was used as an internal control to normalize the RNA concentration. Primers used for transcriptional analyses are listed in Table S3.</p></sec><sec id="s4-5"><title>Expression and purification of LodR1-His<sub>6</sub>, LodR2-His<sub>6</sub>, and Las3-His<sub>6</sub> proteins.</title><p>The <italic toggle="yes">lodR1</italic>, <italic toggle="yes">lodR2</italic>, <italic toggle="yes">lodR3</italic>, and <italic toggle="yes">las3</italic> coding regions were amplified using primer pairs lodR1-orf-F/lodR1-orf-R, lodR2-orf-F/lodR2-orf-R, lodR3-orf-F/lodR3-orf-R, and las3-orf-F/las3-orf-R (Table S3), respectively. The amplified fragments were digested with NdeI and XhoI and then inserted into the same sites of pET23b or pET28a to generate the expression plasmids. The recombinant plasmids were confirmed by sequencing and subsequently introduced into <named-content content-type="genus-species">E. coli</named-content> BL21(DE3) for protein expression. The transformants were grown in LB medium with 100&#x02009;&#x003bc;g/mL ampicillin at 37&#x000b0;C to an optical density at 600&#x02009;nm (OD<sub>600</sub>) of 0.6. Isopropyl-&#x003b2;-<sc>d</sc>-thiogalactopyranoside was then added to a final concentration of 0.1&#x02009;mM, and the cultures were incubated for an additional 16&#x02009;h at 28&#x000b0;C. The recombinant proteins were purified using nickel-nitrilotriacetic acid (Ni-NTA) agarose chromatography according to the manufacturer&#x02019;s protocol (Novagen). Protein purity was determined by Coomassie blue staining after SDS-PAGE on a 10% polyacrylamide gel. The concentration of protein was determined according to the protocol of a bicinchoninic acid (BCA) protein assay kit (Novagen). The purified proteins were stored at 4&#x000b0;C.</p></sec><sec id="s4-6"><title>EMSAs and DNase I footprinting.</title><p>EMSAs were performed mainly as previously described (<xref rid="B50" ref-type="bibr">50</xref>). DNA probes covering the intergenic regions were amplified using primer pairs listed in Table S3. The probe (10&#x02009;ng) was incubated individually with various quantities of the recombinant proteins at 25&#x000b0;C for 25&#x02009;min in a buffer containing 20&#x02009;mM Tris-HCl (pH 7.5), 1&#x02009;mM dithiothreitol (DTT), 10&#x02009;mM MgCl<sub>2</sub>, 0.5&#x02009;&#x003bc;g/&#x003bc;L calf bovine serum albumin (BSA), and 5% (vol/vol) glycerol in a total volume of 20&#x02009;&#x003bc;L. After incubation, protein-bound and free DNAs were separated by electrophoresis on nondenaturing 4.5% (wt/vol) polyacrylamide gels. Gels were stained with SYBR gold (Invitrogen), and the images were captured by a Bio-Rad GelDoc 2000 system.</p><p>DNase I footprinting assays were performed as previously described (<xref rid="B51" ref-type="bibr">51</xref>), with slight modifications. To determine the LodR1- and LodR2-binding sites, <sup>32</sup>P-labeled probes P<italic toggle="yes"><sub>R1&#x02013;A</sub></italic> and P<italic toggle="yes"><sub>R2&#x02013;E</sub></italic> were amplified by PCR with the labeled primers (Table S3). The footprinting reaction mixture contained 30,000&#x02009;cpm of the <sup>32</sup>P-labeled DNA probe, 0.2 to 1&#x02009;&#x003bc;M LodR1-His<sub>6</sub> or LodR2-His<sub>6</sub>, and 2.5&#x02009;&#x003bc;g of poly(dI-dC) (Sigma) in 50&#x02009;&#x003bc;L of EMSA buffer. After incubation at 25&#x000b0;C for 25&#x02009;min, 5.5&#x02009;&#x003bc;L RQ1 RNase-free DNase buffer and 0.2&#x02009;U DNase I were added to the above-described reaction mixture, followed by further incubation at 25&#x000b0;C for 70&#x02009;s. Next, the reaction was stopped by the addition of 50&#x02009;&#x003bc;L of stop solution (20&#x02009;mM EGTA, pH 8.0) and 100&#x02009;&#x003bc;L of phenol-CH<sub>3</sub>Cl (1:1, vol/vol) to the mixture. DNA fragments in the mixture were precipitated by the addition of an equal volume of isopropanol, and the pellet was washed with 75% (vol/vol) ethanol. The samples were resuspended, denatured, and electrophoretically fractionated according to previously described procedures (<xref rid="B51" ref-type="bibr">51</xref>). The sequencing ladder was made using the Silver Sequence DNA sequencing system (Promega, USA). After electrophoresis, the gels were dried and exposed to Kodak X-ray film. To determine the Las3-binding sites on P<italic toggle="yes"><sub>las2&#x02013;3</sub></italic>, the DNA probe was amplified by PCR with 5&#x02032;-fluorescein amidite (FAM)-labeled primer pairs. Different concentrations of Las3-His<sub>6</sub> and 400&#x02009;ng of the labeled DNA probe were incubated in EMSA buffer for 25&#x02009;min at 25&#x000b0;C. Next, samples were digested by DNase I (Promega) at 25&#x000b0;C for 45&#x02009;s, and digestion was terminated with 20&#x02009;mM EGTA. After phenol-chloroform extraction and ethanol precipitation, the resulting DNA samples were subsequently loaded onto an Applied Biosystems 3730 DNA analyzer. GeneMarker v2.2.0 software was used to analyze the DNA regions protected by Las3.</p></sec><sec id="s4-7"><title><italic toggle="yes">gusA</italic> transcriptional fusion assays.</title><p>The <italic toggle="yes">gusA</italic> reporter system was constructed as previously described (<xref rid="B33" ref-type="bibr">33</xref>). Briefly, the putative promoter region from <italic toggle="yes">lod</italic> was inserted into the upstream region of a promoterless <italic toggle="yes">gusA</italic> gene to generate pIJ10500::P<italic toggle="yes"><sub>x</sub></italic>-<italic toggle="yes">gusA</italic> plasmids (P<italic toggle="yes"><sub>x</sub></italic> represents the promoters of the <italic toggle="yes">lod</italic> genes tested). The authenticity of each recombinant plasmid was confirmed by subsequent sequencing. The recombinant plasmid was introduced into <named-content content-type="genus-species">S. coelicolor</named-content> M1146 via <named-content content-type="genus-species">E. coli</named-content>-<italic toggle="yes">Streptomyces</italic> conjugal transfer and integrated into the <italic toggle="yes">Streptomyces</italic> chromosome at the &#x003a6;BT1 <italic toggle="yes">attB</italic> site. The resultant <named-content content-type="genus-species">S. coelicolor</named-content> M1146 derivative strains were used as negative controls in &#x003b2;-glucuronidase (GUS) assays and as conjugation recipients for the overexpression of <italic toggle="yes">lodR3</italic>. Subsequently, pSET152::P<italic toggle="yes"><sub>kasO</sub></italic><sub>*</sub><italic toggle="yes">lodR3C</italic> containing <italic toggle="yes">lodR3</italic> driven by P<italic toggle="yes"><sub>kasO</sub></italic><sub>*</sub> was introduced into the M1146 derivatives in which <italic toggle="yes">gusA</italic> was controlled by different promoters of <italic toggle="yes">lod</italic> genes. The resultant strains were cultured on AS-1 (0.1% yeast extract, 0.5% soluble starch, 0.25% NaCl, 1% Na<sub>2</sub>SO<sub>4</sub>, 0.02% <sc>l</sc>-Ala, 0.02% <sc>l</sc>-Arg, 0.05% <sc>l</sc>-Asn) agar with 5-bromo-4-chloro-3-indolyl-&#x003b2;-<sc>d</sc>-glucuronide (X-Gluc) at a final concentration of 100&#x02009;&#x003bc;M at 28&#x000b0;C for 72&#x02009;h to observe the chromogenic reaction.</p></sec><sec id="s4-8"><title>Statistical analysis.</title><p>For each gene disruption, at least three individual mutants were tested. Other experiments were performed at least in biological triplicate unless otherwise stated, and the data are presented as means &#x000b1; standard deviations (SD). Statistical significance was analyzed by unpaired two-tailed Student&#x02019;s <italic toggle="yes">t</italic> test. <italic toggle="yes">P</italic> values of &#x0003c;0.05 were considered statistically significant.</p></sec></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="d96e244"><caption><title>Reviewer comments</title></caption><media xlink:href="reviewer-comments.pdf"/></supplementary-material></sec></body><back><ack><title>ACKNOWLEDGMENTS</title><p>This work was supported by grants from the China Manned Space Engineering Program (CMSE) (YYWT-0801-EXP-08) and the National Natural Science Foundation of China (31700008 and 81773615). The funders had no role in the study design, data collection and interpretation, or the decision to submit the work for publication.</p><p>We declare that we have no conflict of interest.</p></ack><fn-group><fn fn-type="supplementary-material"><p>Supplemental material is available online only.</p><p>
<supplementary-material id="SuF1" position="float" content-type="local-data"><object-id pub-id-type="doi">10.1128/spectrum.03852-22.1</object-id><label>Supplemental file 1</label><caption><p>Supplemental material. Download <inline-supplementary-material id="SF1" xlink:href="spectrum.03852-22-s0001.pdf" content-type="local-data">spectrum.03852-22-s0001.pdf, PDF file, 0.6 MB</inline-supplementary-material></p></caption></supplementary-material>
</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="B1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Berdy</surname>
<given-names>J</given-names></string-name></person-group>. <year>2005</year>. <article-title>Bioactive microbial metabolites&#x02014;a personal view</article-title>. <source>J Antibiot</source>
<volume>58</volume>:<fpage>1</fpage>&#x02013;<lpage>26</lpage>. doi:<pub-id pub-id-type="doi">10.1038/ja.2005.1</pub-id>.</mixed-citation></ref><ref id="B2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kevin</surname>
<given-names>DA</given-names></string-name>, <string-name><surname>Meujo</surname>
<given-names>DAF</given-names></string-name>, <string-name><surname>Hamann</surname>
<given-names>MT</given-names></string-name></person-group>. <year>2009</year>. <article-title>Polyether ionophores: broad-spectrum and promising biologically active molecules for the control of drug-resistant bacteria and parasites</article-title>. <source>Expert Opin Drug Discov</source>
<volume>4</volume>:<fpage>109</fpage>&#x02013;<lpage>146</lpage>. doi:<pub-id pub-id-type="doi">10.1517/17460440802661443</pub-id>.<pub-id pub-id-type="pmid">23480512</pub-id></mixed-citation></ref><ref id="B3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Huczynski</surname>
<given-names>A</given-names></string-name></person-group>. <year>2012</year>. <article-title>Polyether ionophores&#x02014;promising bioactive molecules for cancer therapy</article-title>. <source>Bioorg Med Chem Lett</source>
<volume>22</volume>:<fpage>7002</fpage>&#x02013;<lpage>7010</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.bmcl.2012.09.046</pub-id>.<pub-id pub-id-type="pmid">23063400</pub-id></mixed-citation></ref><ref id="B4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Johnson</surname>
<given-names>SM</given-names></string-name>, <string-name><surname>Herrin</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Paul</surname>
<given-names>IC</given-names></string-name></person-group>. <year>1970</year>. <article-title>Crystal and molecular structure of barium salt of an antibiotic containing a high proportion of oxygen</article-title>. <source>J Am Chem Soc</source>
<volume>92</volume>:<fpage>4428</fpage>&#x02013;<lpage>4435</lpage>. doi:<pub-id pub-id-type="doi">10.1021/ja00717a047</pub-id>.<pub-id pub-id-type="pmid">5428386</pub-id></mixed-citation></ref><ref id="B5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mitrovic</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Schildknecht</surname>
<given-names>EG</given-names></string-name>, <string-name><surname>Marusich</surname>
<given-names>WL</given-names></string-name></person-group>. <year>1975</year>. <article-title>Comparative anticoccidial activity and compatibility of lasalocid in broiler chickens</article-title>. <source>Poult Sci</source>
<volume>54</volume>:<fpage>757</fpage>&#x02013;<lpage>761</lpage>. doi:<pub-id pub-id-type="doi">10.3382/ps.0540757</pub-id>.</mixed-citation></ref><ref id="B6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Paterson</surname>
<given-names>JA</given-names></string-name>, <string-name><surname>Anderson</surname>
<given-names>BM</given-names></string-name>, <string-name><surname>Bowman</surname>
<given-names>DK</given-names></string-name>, <string-name><surname>Morrison</surname>
<given-names>RL</given-names></string-name>, <string-name><surname>Williams</surname>
<given-names>JE</given-names></string-name></person-group>. <year>1983</year>. <article-title>Effect of protein source and lasalocid on nitrogen digestibility and growth by ruminants</article-title>. <source>J Anim Sci</source>
<volume>57</volume>:<fpage>1537</fpage>&#x02013;<lpage>1544</lpage>. doi:<pub-id pub-id-type="doi">10.2527/jas1983.5761537x</pub-id>.<pub-id pub-id-type="pmid">6674290</pub-id></mixed-citation></ref><ref id="B7"><label>7</label><mixed-citation publication-type="book"><person-group person-group-type="author"><string-name><surname>Anad&#x000f3;n</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Mart&#x000ed;nez-Larra&#x000f1;aga</surname>
<given-names>MR</given-names></string-name></person-group>. <year>2014</year>. <part-title>Veterinary drugs residues: coccidiostats</part-title>, p <fpage>63</fpage>&#x02013;<lpage>75</lpage>. <italic toggle="yes">In</italic>
<person-group person-group-type="editor"><string-name><surname>Motarjemi</surname>
<given-names>Y</given-names></string-name></person-group> (ed), <source>Encyclopedia of food safety.</source>
<publisher-name>Academic Press</publisher-name>, <publisher-loc>Waltham, MA</publisher-loc>.</mixed-citation></ref><ref id="B8"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mahtal</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Wu</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Cintrat</surname>
<given-names>J-C</given-names></string-name>, <string-name><surname>Barbier</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Lemichez</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Gillet</surname>
<given-names>D</given-names></string-name></person-group>. <year>2020</year>. <article-title>Revisiting old ionophore lasalocid as a novel inhibitor of multiple toxins</article-title>. <source>Toxins (Basel)</source>
<volume>12</volume>:<fpage>26</fpage>. doi:<pub-id pub-id-type="doi">10.3390/toxins12010026</pub-id>.<pub-id pub-id-type="pmid">31906353</pub-id></mixed-citation></ref><ref id="B9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gupta</surname>
<given-names>PB</given-names></string-name>, <string-name><surname>Onder</surname>
<given-names>TT</given-names></string-name>, <string-name><surname>Jiang</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Tao</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Kuperwasser</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Weinberg</surname>
<given-names>RA</given-names></string-name>, <string-name><surname>Lander</surname>
<given-names>ES</given-names></string-name></person-group>. <year>2009</year>. <article-title>Identification of selective inhibitors of cancer stem cells by high-throughput screening</article-title>. <source>Cell</source>
<volume>138</volume>:<fpage>645</fpage>&#x02013;<lpage>659</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cell.2009.06.034</pub-id>.<pub-id pub-id-type="pmid">19682730</pub-id></mixed-citation></ref><ref id="B10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Antoszczak</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Otto-&#x0015a;lusarczyk</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Kordylas</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Struga</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Huczy&#x00144;ski</surname>
<given-names>A</given-names></string-name></person-group>. <year>2022</year>. <article-title>Synthesis of lasalocid-based bioconjugates and evaluation of their anticancer activity</article-title>. <source>ACS Omega</source>
<volume>7</volume>:<fpage>1943</fpage>&#x02013;<lpage>1955</lpage>. doi:<pub-id pub-id-type="doi">10.1021/acsomega.1c05434</pub-id>.<pub-id pub-id-type="pmid">35071884</pub-id></mixed-citation></ref><ref id="B11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhu</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Yu</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Guo</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Luo</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Mao</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Guan</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>Y</given-names></string-name></person-group>. <year>2017</year>. <article-title>SlnR is a positive pathway-specific regulator for salinomycin biosynthesis in Streptomyces albus</article-title>. <source>Appl Microbiol Biotechnol</source>
<volume>101</volume>:<fpage>1547</fpage>&#x02013;<lpage>1557</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00253-016-7918-5</pub-id>.<pub-id pub-id-type="pmid">27830292</pub-id></mixed-citation></ref><ref id="B12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wei</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Ma</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Guo</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Xu</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Xie</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Pan</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Zhou</surname>
<given-names>Z</given-names></string-name></person-group>. <year>2022</year>. <article-title>Characterization of pathway-specific regulator NigR for high yield production of nigericin in Streptomyces malaysiensis F913</article-title>. <source>Antibiotics (Basel)</source>
<volume>11</volume>:<fpage>938</fpage>. doi:<pub-id pub-id-type="doi">10.3390/antibiotics11070938</pub-id>.<pub-id pub-id-type="pmid">35884192</pub-id></mixed-citation></ref><ref id="B13"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yu</surname>
<given-names>Q</given-names></string-name>, <string-name><surname>Du</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Deng</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>He</surname>
<given-names>X</given-names></string-name></person-group>. <year>2012</year>. <article-title>The biosynthesis of the polyether antibiotic nanchangmycin is controlled by two pathway-specific transcriptional activators</article-title>. <source>Arch Microbiol</source>
<volume>194</volume>:<fpage>415</fpage>&#x02013;<lpage>426</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00203-011-0768-8</pub-id>.<pub-id pub-id-type="pmid">22109812</pub-id></mixed-citation></ref><ref id="B14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tang</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Pang</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Lin</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Qiao</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Zhao</surname>
<given-names>G</given-names></string-name></person-group>. <year>2017</year>. <article-title>Characterization of three pathway-specific regulators for high production of monensin in Streptomyces cinnamonensis</article-title>. <source>Appl Microbiol Biotechnol</source>
<volume>101</volume>:<fpage>6083</fpage>&#x02013;<lpage>6097</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00253-017-8353-y</pub-id>.<pub-id pub-id-type="pmid">28685195</pub-id></mixed-citation></ref><ref id="B15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Lin</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Tang</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Qiao</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Zhao</surname>
<given-names>G</given-names></string-name></person-group>. <year>2016</year>. <article-title>DasR positively controls monensin production at two-level regulation in Streptomyces cinnamonensis</article-title>. <source>J Ind Microbiol Biotechnol</source>
<volume>43</volume>:<fpage>1681</fpage>&#x02013;<lpage>1692</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s10295-016-1845-4</pub-id>.<pub-id pub-id-type="pmid">27718094</pub-id></mixed-citation></ref><ref id="B16"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Minami</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Oguri</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Watanabe</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Oikawa</surname>
<given-names>H</given-names></string-name></person-group>. <year>2013</year>. <article-title>Biosynthetic machinery of ionophore polyether lasalocid: enzymatic construction of polyether skeleton</article-title>. <source>Curr Opin Chem Biol</source>
<volume>17</volume>:<fpage>555</fpage>&#x02013;<lpage>561</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cbpa.2013.06.004</pub-id>.<pub-id pub-id-type="pmid">23796908</pub-id></mixed-citation></ref><ref id="B17"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mavrodi</surname>
<given-names>DV</given-names></string-name>, <string-name><surname>Peever</surname>
<given-names>TL</given-names></string-name>, <string-name><surname>Mavrodi</surname>
<given-names>OV</given-names></string-name>, <string-name><surname>Parejko</surname>
<given-names>JA</given-names></string-name>, <string-name><surname>Raaijmakers</surname>
<given-names>JM</given-names></string-name>, <string-name><surname>Lemanceau</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Mazurier</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Heide</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Blankenfeldt</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Weller</surname>
<given-names>DM</given-names></string-name>, <string-name><surname>Thomashow</surname>
<given-names>LS</given-names></string-name></person-group>. <year>2010</year>. <article-title>Diversity and evolution of the phenazine biosynthesis pathway</article-title>. <source>Appl Environ Microbiol</source>
<volume>76</volume>:<fpage>866</fpage>&#x02013;<lpage>879</lpage>. doi:<pub-id pub-id-type="doi">10.1128/AEM.02009-09</pub-id>.<pub-id pub-id-type="pmid">20008172</pub-id></mixed-citation></ref><ref id="B18"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Osbourn</surname>
<given-names>A</given-names></string-name></person-group>. <year>2010</year>. <article-title>Secondary metabolic gene clusters: evolutionary toolkits for chemical innovation</article-title>. <source>Trends Genet</source>
<volume>26</volume>:<fpage>449</fpage>&#x02013;<lpage>457</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.tig.2010.07.001</pub-id>.<pub-id pub-id-type="pmid">20739089</pub-id></mixed-citation></ref><ref id="B19"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chavadi</surname>
<given-names>SS</given-names></string-name>, <string-name><surname>Stirrett</surname>
<given-names>KL</given-names></string-name>, <string-name><surname>Edupuganti</surname>
<given-names>UR</given-names></string-name>, <string-name><surname>Vergnolle</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Sadhanandan</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Marchiano</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Martin</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Qiu</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Soll</surname>
<given-names>CE</given-names></string-name>, <string-name><surname>Quadri</surname>
<given-names>LEN</given-names></string-name></person-group>. <year>2011</year>. <article-title>Mutational and phylogenetic analyses of the mycobacterial mbt gene cluster</article-title>. <source>J Bacteriol</source>
<volume>193</volume>:<fpage>5905</fpage>&#x02013;<lpage>5913</lpage>. doi:<pub-id pub-id-type="doi">10.1128/JB.05811-11</pub-id>.<pub-id pub-id-type="pmid">21873494</pub-id></mixed-citation></ref><ref id="B20"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Amos</surname>
<given-names>GCA</given-names></string-name>, <string-name><surname>Awakawa</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Tuttle</surname>
<given-names>RN</given-names></string-name>, <string-name><surname>Letzel</surname>
<given-names>A-C</given-names></string-name>, <string-name><surname>Kim</surname>
<given-names>MC</given-names></string-name>, <string-name><surname>Kudo</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Fenical</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Moore</surname>
<given-names>BS</given-names></string-name>, <string-name><surname>Jensen</surname>
<given-names>PR</given-names></string-name></person-group>. <year>2017</year>. <article-title>Comparative transcriptomics as a guide to natural product discovery and biosynthetic gene cluster functionality</article-title>. <source>Proc Natl Acad Sci USA</source>
<volume>114</volume>:<fpage>E11121</fpage>&#x02013;<lpage>E11130</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.1714381115</pub-id>.<pub-id pub-id-type="pmid">29229817</pub-id></mixed-citation></ref><ref id="B21"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Busch</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Agarwal</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Schorn</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Machado</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Moore</surname>
<given-names>BS</given-names></string-name>, <string-name><surname>Rouse</surname>
<given-names>GW</given-names></string-name>, <string-name><surname>Gram</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Jensen</surname>
<given-names>PR</given-names></string-name></person-group>. <year>2019</year>. <article-title>Diversity and distribution of the bmp gene cluster and its polybrominated products in the genus Pseudoalteromonas</article-title>. <source>Environ Microbiol</source>
<volume>21</volume>:<fpage>1575</fpage>&#x02013;<lpage>1585</lpage>. doi:<pub-id pub-id-type="doi">10.1111/1462-2920.14532</pub-id>.<pub-id pub-id-type="pmid">30652406</pub-id></mixed-citation></ref><ref id="B22"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Smith</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Hong</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Spencer</surname>
<given-names>JB</given-names></string-name>, <string-name><surname>Leadlay</surname>
<given-names>PF</given-names></string-name></person-group>. <year>2008</year>. <article-title>Analysis of specific mutants in the lasalocid gene cluster: evidence for enzymatic catalysis of a disfavoured polyether ring closure</article-title>. <source>Chembiochem</source>
<volume>9</volume>:<fpage>2967</fpage>&#x02013;<lpage>2975</lpage>. doi:<pub-id pub-id-type="doi">10.1002/cbic.200800585</pub-id>.<pub-id pub-id-type="pmid">19025863</pub-id></mixed-citation></ref><ref id="B23"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Migita</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Watanabe</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Hirose</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Watanabe</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Tokiwano</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Kinashi</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Oikawa</surname>
<given-names>H</given-names></string-name></person-group>. <year>2009</year>. <article-title>Identification of a gene cluster of polyether antibiotic lasalocid from Streptomyces lasaliensis</article-title>. <source>Biosci Biotechnol Biochem</source>
<volume>73</volume>:<fpage>169</fpage>&#x02013;<lpage>176</lpage>. doi:<pub-id pub-id-type="doi">10.1271/bbb.80631</pub-id>.<pub-id pub-id-type="pmid">19129623</pub-id></mixed-citation></ref><ref id="B24"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Xi</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Rong</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Ruan</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Huang</surname>
<given-names>Y</given-names></string-name></person-group>. <year>2011</year>. <article-title>Genetic screening strategy for rapid access to polyether ionophore producers and products in actinomycetes</article-title>. <source>Appl Environ Microbiol</source>
<volume>77</volume>:<fpage>3433</fpage>&#x02013;<lpage>3442</lpage>. doi:<pub-id pub-id-type="doi">10.1128/AEM.02915-10</pub-id>.<pub-id pub-id-type="pmid">21421776</pub-id></mixed-citation></ref><ref id="B25"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Guo</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Ding</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Shang</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Gao</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Ruan</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Huang</surname>
<given-names>Y</given-names></string-name></person-group>. <year>2015</year>. <article-title>Red soils harbor diverse culturable actinomycetes that are promising sources of novel secondary metabolites</article-title>. <source>Appl Environ Microbiol</source>
<volume>81</volume>:<fpage>3086</fpage>&#x02013;<lpage>3103</lpage>. doi:<pub-id pub-id-type="doi">10.1128/AEM.03859-14</pub-id>.<pub-id pub-id-type="pmid">25724963</pub-id></mixed-citation></ref><ref id="B26"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Liu</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Shang</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Huang</surname>
<given-names>Y</given-names></string-name></person-group>. <year>2016</year>. <article-title>Activation and identification of NC-1: a cryptic cyclodepsipeptide from red soil-derived Streptomyces sp. FXJ1.172</article-title>. <source>Eur J Org Chem</source>
<volume>2016</volume>:<fpage>3943</fpage>&#x02013;<lpage>3948</lpage>. doi:<pub-id pub-id-type="doi">10.1002/ejoc.201600297</pub-id>.</mixed-citation></ref><ref id="B27"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cuthbertson</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Nodwell</surname>
<given-names>JR</given-names></string-name></person-group>. <year>2013</year>. <article-title>The TetR family of regulators</article-title>. <source>Microbiol Mol Biol Rev</source>
<volume>77</volume>:<fpage>440</fpage>&#x02013;<lpage>475</lpage>. doi:<pub-id pub-id-type="doi">10.1128/MMBR.00018-13</pub-id>.<pub-id pub-id-type="pmid">24006471</pub-id></mixed-citation></ref><ref id="B28"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Deng</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Xie</surname>
<given-names>J</given-names></string-name></person-group>. <year>2013</year>. <article-title>The underling [<italic toggle="yes">sic</italic>] mechanism of bacterial TetR/AcrR family transcriptional repressors</article-title>. <source>Cell Signal</source>
<volume>25</volume>:<fpage>1608</fpage>&#x02013;<lpage>1613</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cellsig.2013.04.003</pub-id>.<pub-id pub-id-type="pmid">23602932</pub-id></mixed-citation></ref><ref id="B29"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wilkinson</surname>
<given-names>SP</given-names></string-name>, <string-name><surname>Grove</surname>
<given-names>A</given-names></string-name></person-group>. <year>2006</year>. <article-title>Ligand-responsive transcriptional regulation by members of the MarR family of winged helix proteins</article-title>. <source>Curr Issues Mol Biol</source>
<volume>8</volume>:<fpage>51</fpage>&#x02013;<lpage>62</lpage>.<pub-id pub-id-type="pmid">16450885</pub-id></mixed-citation></ref><ref id="B30"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhu</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Ikeda</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Deng</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Cane</surname>
<given-names>DE</given-names></string-name></person-group>. <year>2013</year>. <article-title>Product-mediated regulation of pentalenolactone biosynthesis in Streptomyces species by the MarR/SlyA family activators PenR and PntR</article-title>. <source>J Bacteriol</source>
<volume>195</volume>:<fpage>1255</fpage>&#x02013;<lpage>1266</lpage>. doi:<pub-id pub-id-type="doi">10.1128/JB.02079-12</pub-id>.<pub-id pub-id-type="pmid">23316039</pub-id></mixed-citation></ref><ref id="B31"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Oliynyk</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Stark</surname>
<given-names>CB</given-names></string-name>, <string-name><surname>Bhatt</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Jones</surname>
<given-names>MA</given-names></string-name>, <string-name><surname>Hughes-Thomas</surname>
<given-names>ZA</given-names></string-name>, <string-name><surname>Wilkinson</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Oliynyk</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Demydchuk</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Staunton</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Leadlay</surname>
<given-names>PF</given-names></string-name></person-group>. <year>2003</year>. <article-title>Analysis of the biosynthetic gene cluster for the polyether antibiotic monensin in Streptomyces cinnamonensis and evidence for the role of monB and monC genes in oxidative cyclization</article-title>. <source>Mol Microbiol</source>
<volume>49</volume>:<fpage>1179</fpage>&#x02013;<lpage>1190</lpage>. doi:<pub-id pub-id-type="doi">10.1046/j.1365-2958.2003.03571.x</pub-id>.<pub-id pub-id-type="pmid">12940979</pub-id></mixed-citation></ref><ref id="B32"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Liu</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Chater</surname>
<given-names>KF</given-names></string-name>, <string-name><surname>Chandra</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Niu</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Tan</surname>
<given-names>H</given-names></string-name></person-group>. <year>2013</year>. <article-title>Molecular regulation of antibiotic biosynthesis in Streptomyces</article-title>. <source>Microbiol Mol Biol Rev</source>
<volume>77</volume>:<fpage>112</fpage>&#x02013;<lpage>143</lpage>. doi:<pub-id pub-id-type="doi">10.1128/MMBR.00054-12</pub-id>.<pub-id pub-id-type="pmid">23471619</pub-id></mixed-citation></ref><ref id="B33"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Myronovskyi</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Welle</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Fedorenko</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Luzhetskyy</surname>
<given-names>A</given-names></string-name></person-group>. <year>2011</year>. <article-title>&#x003b2;-Glucuronidase as a sensitive and versatile reporter in actinomycetes</article-title>. <source>Appl Environ Microbiol</source>
<volume>77</volume>:<fpage>5370</fpage>&#x02013;<lpage>5383</lpage>. doi:<pub-id pub-id-type="doi">10.1128/AEM.00434-11</pub-id>.<pub-id pub-id-type="pmid">21685164</pub-id></mixed-citation></ref><ref id="B34"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Berger</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Rachlin</surname>
<given-names>AI</given-names></string-name>, <string-name><surname>Scott</surname>
<given-names>WE</given-names></string-name>, <string-name><surname>Sternbach</surname>
<given-names>LH</given-names></string-name>, <string-name><surname>Goldberg</surname>
<given-names>MW</given-names></string-name></person-group>. <year>1951</year>. <article-title>The isolation of three new crystalline antibiotics from Streptomyces</article-title>. <source>J Am Chem Soc</source>
<volume>73</volume>:<fpage>5295</fpage>&#x02013;<lpage>5298</lpage>. doi:<pub-id pub-id-type="doi">10.1021/ja01155a084</pub-id>.</mixed-citation></ref><ref id="B35"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bibb</surname>
<given-names>MJ</given-names></string-name></person-group>. <year>2005</year>. <article-title>Regulation of secondary metabolism in streptomycetes</article-title>. <source>Curr Opin Microbiol</source>
<volume>8</volume>:<fpage>208</fpage>&#x02013;<lpage>215</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.mib.2005.02.016</pub-id>.<pub-id pub-id-type="pmid">15802254</pub-id></mixed-citation></ref><ref id="B36"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ahn</surname>
<given-names>SK</given-names></string-name>, <string-name><surname>Tahlan</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Yu</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Nodwell</surname>
<given-names>JR</given-names></string-name></person-group>. <year>2007</year>. <article-title>Investigation of transcription repression and small-molecule responsiveness by TetR-like transcription factors using a heterologous Escherichia coli-based assay</article-title>. <source>J Bacteriol</source>
<volume>189</volume>:<fpage>6655</fpage>&#x02013;<lpage>6664</lpage>. doi:<pub-id pub-id-type="doi">10.1128/JB.00717-07</pub-id>.<pub-id pub-id-type="pmid">17644591</pub-id></mixed-citation></ref><ref id="B37"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tahlan</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Yu</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Xu</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Davidson</surname>
<given-names>AR</given-names></string-name>, <string-name><surname>Nodwell</surname>
<given-names>JR</given-names></string-name></person-group>. <year>2008</year>. <article-title>Ligand recognition by ActR, a TetR-like regulator of actinorhodin export</article-title>. <source>J Mol Biol</source>
<volume>383</volume>:<fpage>753</fpage>&#x02013;<lpage>761</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jmb.2008.08.081</pub-id>.<pub-id pub-id-type="pmid">18804114</pub-id></mixed-citation></ref><ref id="B38"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Grove</surname>
<given-names>A</given-names></string-name></person-group>. <year>2013</year>. <article-title>MarR family transcription factors</article-title>. <source>Curr Biol</source>
<volume>23</volume>:<fpage>R142</fpage>&#x02013;<lpage>R143</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cub.2013.01.013</pub-id>.<pub-id pub-id-type="pmid">23428319</pub-id></mixed-citation></ref><ref id="B39"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gou</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Han</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Ge</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Hu</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>Z</given-names></string-name></person-group>. <year>2017</year>. <article-title>A novel TetR family transcriptional regulator, CalR3, negatively controls calcimycin biosynthesis in Streptomyces chartreusis NRRL 3882</article-title>. <source>Front Microbiol</source>
<volume>8</volume>:<fpage>2371</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fmicb.2017.02371</pub-id>.<pub-id pub-id-type="pmid">29238338</pub-id></mixed-citation></ref><ref id="B40"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Liu</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Wu</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Kang</surname>
<given-names>Q</given-names></string-name>, <string-name><surname>Yan</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Bai</surname>
<given-names>L</given-names></string-name></person-group>. <year>2022</year>. <article-title>Comparative transcriptome-based mining of genes involved in the export of polyether antibiotics for titer improvement</article-title>. <source>Antibiotics (Basel)</source>
<volume>11</volume>:<fpage>600</fpage>. doi:<pub-id pub-id-type="doi">10.3390/antibiotics11050600</pub-id>.<pub-id pub-id-type="pmid">35625244</pub-id></mixed-citation></ref><ref id="B41"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Roege</surname>
<given-names>KE</given-names></string-name>, <string-name><surname>Kelly</surname>
<given-names>WL</given-names></string-name></person-group>. <year>2009</year>. <article-title>Analysis of the indanomycin biosynthetic gene cluster from Streptomyces antibioticus NRRL 8167</article-title>. <source>Chembiochem</source>
<volume>10</volume>:<fpage>1064</fpage>&#x02013;<lpage>1072</lpage>. doi:<pub-id pub-id-type="doi">10.1002/cbic.200800822</pub-id>.<pub-id pub-id-type="pmid">19301315</pub-id></mixed-citation></ref><ref id="B42"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hwang</surname>
<given-names>JY</given-names></string-name>, <string-name><surname>Hanh</surname>
<given-names>NPK</given-names></string-name>, <string-name><surname>Yoo</surname>
<given-names>JC</given-names></string-name>, <string-name><surname>Seong</surname>
<given-names>CN</given-names></string-name>, <string-name><surname>Nam</surname>
<given-names>DH</given-names></string-name></person-group>. <year>2010</year>. <article-title>The biosynthetic gene cluster for a polyether antibiotic, laidlomycin, from Streptomyces sp. KCTC 10631BP</article-title>. <source>J Biotechnol</source>
<volume>150</volume>:<fpage>374</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jbiotec.2010.09.454</pub-id>.</mixed-citation></ref><ref id="B43"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Leskiw</surname>
<given-names>BK</given-names></string-name>, <string-name><surname>Lawlor</surname>
<given-names>EJ</given-names></string-name>, <string-name><surname>Fernandez-Abalos</surname>
<given-names>JM</given-names></string-name>, <string-name><surname>Chater</surname>
<given-names>KF</given-names></string-name></person-group>. <year>1991</year>. <article-title>TTA codons in some genes prevent their expression in a class of developmental, antibiotic-negative, Streptomyces mutants</article-title>. <source>Proc Natl Acad Sci USA</source>
<volume>88</volume>:<fpage>2461</fpage>&#x02013;<lpage>2465</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.88.6.2461</pub-id>.<pub-id pub-id-type="pmid">1826053</pub-id></mixed-citation></ref><ref id="B44"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Shirling</surname>
<given-names>EB</given-names></string-name>, <string-name><surname>Gottlieb</surname>
<given-names>D</given-names></string-name></person-group>. <year>1966</year>. <article-title>Methods for characterization of Streptomyces species</article-title>. <source>Int J Syst Bacteriol</source>
<volume>16</volume>:<fpage>313</fpage>&#x02013;<lpage>340</lpage>. doi:<pub-id pub-id-type="doi">10.1099/00207713-16-3-313</pub-id>.</mixed-citation></ref><ref id="B45"><label>45</label><mixed-citation publication-type="book"><person-group person-group-type="author"><string-name><surname>Sambrook</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Fritsch</surname>
<given-names>EF</given-names></string-name>, <string-name><surname>Maniatis</surname>
<given-names>T</given-names></string-name></person-group>. <year>1989</year>. <source>Molecular cloning: a laboratory manual</source>, <edition>2nd ed</edition>. <publisher-name>Cold Spring Harbor Laboratory Press</publisher-name>, <publisher-loc>Cold Spring Harbor, NY</publisher-loc>.</mixed-citation></ref><ref id="B46"><label>46</label><mixed-citation publication-type="book"><person-group person-group-type="author"><string-name><surname>Kieser</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Bibb</surname>
<given-names>MJ</given-names></string-name>, <string-name><surname>Buttner</surname>
<given-names>MJ</given-names></string-name>, <string-name><surname>Chater</surname>
<given-names>KF</given-names></string-name>, <string-name><surname>Hopwood</surname>
<given-names>DA</given-names></string-name></person-group>. <year>2000</year>. <source>Practical Streptomyces genetics.</source>
<publisher-name>John Innes Foundation</publisher-name>, <publisher-loc>Norwich, United Kingdom</publisher-loc>.</mixed-citation></ref><ref id="B47"><label>47</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Liu</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Song</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Shang</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Anderson</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Fox</surname>
<given-names>DJ</given-names></string-name>, <string-name><surname>Challis</surname>
<given-names>GL</given-names></string-name>, <string-name><surname>Huang</surname>
<given-names>Y</given-names></string-name></person-group>. <year>2016</year>. <article-title>Unique post-translational oxime formation in the biosynthesis of the azolemycin complex of novel ribosomal peptides from Streptomyces sp. FXJ1.264</article-title>. <source>Chem Sci</source>
<volume>7</volume>:<fpage>482</fpage>&#x02013;<lpage>488</lpage>. doi:<pub-id pub-id-type="doi">10.1039/C5SC03021H</pub-id>.<pub-id pub-id-type="pmid">28791101</pub-id></mixed-citation></ref><ref id="B48"><label>48</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Liu</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Tian</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Yang</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Tan</surname>
<given-names>H</given-names></string-name></person-group>. <year>2005</year>. <article-title>A pathway-specific transcriptional regulatory gene for nikkomycin biosynthesis in Streptomyces ansochromogenes that also influences colony development</article-title>. <source>Mol Microbiol</source>
<volume>55</volume>:<fpage>1855</fpage>&#x02013;<lpage>1866</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1365-2958.2005.04512.x</pub-id>.<pub-id pub-id-type="pmid">15752205</pub-id></mixed-citation></ref><ref id="B49"><label>49</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Xie</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Tian</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Yang</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>W</given-names></string-name>, <string-name><surname>You</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Deng</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Tan</surname>
<given-names>H</given-names></string-name></person-group>. <year>2009</year>. <article-title>polR, a pathway-specific transcriptional regulatory gene, positively controls polyoxin biosynthesis in Streptomyces cacaoi subsp. asoensis</article-title>. <source>Microbiology (Reading)</source>
<volume>155</volume>:<fpage>1819</fpage>&#x02013;<lpage>1831</lpage>. doi:<pub-id pub-id-type="doi">10.1099/mic.0.028639-0</pub-id>.<pub-id pub-id-type="pmid">19383687</pub-id></mixed-citation></ref><ref id="B50"><label>50</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yang</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Xie</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Tian</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Tan</surname>
<given-names>H</given-names></string-name></person-group>. <year>2007</year>. <article-title>The tyrosine degradation gene hppD is transcriptionally activated by HpdA and HpdR in Streptomyces coelicolor, while hpdA is negatively autoregulated and repressed by HpdR</article-title>. <source>Mol Microbiol</source>
<volume>65</volume>:<fpage>1064</fpage>&#x02013;<lpage>1077</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1365-2958.2007.05848.x</pub-id>.<pub-id pub-id-type="pmid">17640269</pub-id></mixed-citation></ref><ref id="B51"><label>51</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wei</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Tian</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Niu</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Tan</surname>
<given-names>H</given-names></string-name></person-group>. <year>2014</year>. <article-title>GouR, a TetR family transcriptional regulator, coordinates the biosynthesis and export of gougerotin in Streptomyces graminearus</article-title>. <source>Appl Environ Microbiol</source>
<volume>80</volume>:<fpage>714</fpage>&#x02013;<lpage>722</lpage>. doi:<pub-id pub-id-type="doi">10.1128/AEM.03003-13</pub-id>.<pub-id pub-id-type="pmid">24242236</pub-id></mixed-citation></ref></ref-list></back></article>